Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
1451/2007 • 32007R1451
Legal Acts - Regulations
- Inbound citations: 480
- •
- Cited paragraphs: 9
- •
- Outbound citations: 75
11.12.2007
EN
Official Journal of the European Union
L 325/3
COMMISSION REGULATION (EC) No 1451/2007
of 4 December 2007
on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (1), and in particular Article 16(2) thereof,
Whereas:
(1)
Pursuant to Directive 98/8/EC, Member States may only authorise the placing on the market of biocidal products containing active substances included in Annex I, IA or IB to that Directive. However, under the transitional measures provided for in Article 16(1) of Directive 98/8/EC Member States may allow the placing on the market of biocidal products containing active substances not listed in Annex I, IA or IB to Directive 98/8/EC which were already on the market on 14 May 2000, hereinafter ‘existing active substances’. Pursuant to paragraph 2 of that same Article, a 10-year programme of work is to be carried out for the review of all existing active substances. This programme of work was intended to identify the existing active substances and determine those to be evaluated under the review programme with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
(2)
The initial phase of the programme was laid down in Commission Regulation (EC) No 1896/2000 of 7 September 2000 on the first phase of the programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council on biocidal products (2).
(3)
Under Regulation (EC) No 1896/2000, existing active substances for use in biocidal products had to be identified, and those to be evaluated with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC in one or more product types had to be notified no later than 28 March 2002.
(4)
Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 (3) established a list of existing active substances. That list covered active substances that had been identified in accordance with Article 3(1) or Article 5(2) of Regulation (EC) No 1896/2000 or in respect of which equivalent information had been submitted in a notification in accordance with Article 4(1) of that Regulation.
(5)
Regulation (EC) No 2032/2003 also established, in Annex II, an exhaustive list of existing active substances to be evaluated under the review programme. That list covered active substances in respect of which at least one notification had been accepted in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or in which a Member State had expressed an interest in accordance with Article 5(3) of that Regulation. That list specified the product types concerned.
(6)
Regulation (EC) No 2032/2003 allowed for a number of active substances or substance/product type combinations that were not originally covered by the review programme, to be examined on the same conditions as the active substances evaluated under the review programme, provided that interested operators submitted complete dossiers before 1 March 2006.
(7)
Article 4(2) of Regulation (EC) No 2032/2003 set 1 September 2006 as the date from which products containing active substances not examined under the review programme should be withdrawn from the market.
(8)
Article 4(3) of Regulation (EC) No 2032/2003 provided that the existing active substances that had not been identified by the persons using them in biocidal products were to be deemed not to have been placed on the market for biocidal purposes before 14 May 2000. However, this assimilation to new active substances should not be taken to mean that the unlawfully non-identified existing active substances may benefit from a provisional authorisation or from the longer data protection period reserved to genuinely new active substances. Whereas a clarification in that sense should be added to that provision.
(9)
Regulation (EC) No 2032/2003 introduced the possibility for Member States to apply for a derogation for biocidal products containing identified existing active substances that are not examined under the review programme, which Member States claim are essential for reasons of health, safety, or protection of cultural heritage or critical for the functioning of society in the absence of technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment or health. Such derogation is granted to the requesting Member States only if the requests are justified, if continued use does not give rise to concerns for human health and the environment, and if, where appropriate, alternatives are being developed. It is appropriate to continue to allow Member States to apply for such a derogation, including in respect of an active substance which it has been decided not to include in Annex I, IA or IB to Directive 98/8/EC. Since the review programme referred to in Article 16(2) of Directive 98/8/EC runs only until 14 May 2010, any such derogation should not continue beyond that date.
(10)
Certain substances or products that are normally consumed by humans or animals for their subsistence may also be used to attract or to repel harmful organisms. For these substances, there is general agreement that the authorisation/registration requirements of Directive 98/8/EC seem unjustified and that they should be expressly excluded from its scope. Considering that a revision of Directive 98/8/EC will take a significant amount of time during which the viability of those products on the market might be irreversibly affected, it is appropriate to postpone their withdrawal from the market until 14 May 2010.
(11)
A Member State which has indicated an interest in seeking review of a particular active substance should not be designated Rapporteur Member State for that substance.
(12)
In order to avoid duplication of work, and in particular to reduce testing involving vertebrate animals, the requirements concerning preparation and submission of the complete dossier should be such as to encourage those whose notifications have been accepted, hereinafter ‘participants’, to act collectively, in particular by submitting collective dossiers. It should be possible for the Rapporteur Member State to make available the reference to any test involving vertebrate animals that has been carried out in respect of a notified existing active substance unless that reference is confidential under Article 19 of Directive 98/8/EC. Also, in order to gain experience on the appropriateness of data requirements and to ensure that the review of active substances is carried out in a cost-effective way, participants should be encouraged to provide information on the costs of compiling a dossier and on the need to carry out tests on vertebrate animals.
(13)
In order to avoid delays, participants should start discussions as early as possible with Rapporteur Member States in order to resolve uncertainties in relation to data requirements. Applicants, other than participants, who wish to apply in accordance with Article 11 of Directive 98/8/EC for inclusion in Annex I, IA or IB thereto of an active substance/product type combination being evaluated under the review programme should submit complete dossiers for that combination no earlier or no later than participants so as not to disturb the smooth functioning of the review programme or create a disadvantage to the participants.
(14)
The requirements concerning the content and format of dossiers and the number of dossiers to be submitted should be defined.
(15)
Provision should be made for cases in which a participant is joined by a producer, formulator or association and in which a participant withdraws from the review programme.
(16)
Producers, formulators or associations should within certain time limits have the opportunity of taking over the role of participant for an existing active substance/product type combination in respect of which all participants have withdrawn or none of the dossiers meets the requirements. Subject to the same time-limits, it should also be possible in certain circumstances for Member States to indicate an interest and act as a participant for the inclusion in Annex I, IA or IB to Directive 98/8/EC of such a combination.
(17)
In order to discourage abuse of the opportunity to maintain an active substance on the market while it is examined under the review programme, it should be possible for another person or a Member State to take over the role of participant only once in relation to a given active substance/product type combination. For the same purpose, a person or Member State taking over the role of participant should provide within a certain period evidence of commencing work on a complete dossier.
(18)
Time limits should be specified within which the Rapporteur Member States must verify the completeness of the dossiers. It should be possible, in exceptional circumstances, for the Rapporteur Member States to establish a new deadline for the submission of parts of a dossier, in particular where the participant has demonstrated that it was impossible to submit information in due time or in order to resolve uncertainties regarding data requirements that remain despite earlier discussions between the participant and the Rapporteur Member State.
(19)
For each existing active substance, the Rapporteur Member State should examine and evaluate the dossier and present the results to the Commission and the other Member States in the form of a competent authority report and a recommendation as to the decision to be taken with regard to the active substance concerned. In order not to prolong decision-making unnecessarily, the Rapporteur Member State should at the same time consider carefully the need for additional studies. For the same reason, Rapporteur Member States should be obliged to take into consideration information submitted after acceptance of the dossier only under specified conditions.
(20)
The competent authority reports should be examined by the other Member States before the assessment reports are submitted to the Standing Committee on Biocidal Products.
(21)
Where, despite a recommendation for inclusion of an active substance in Annex I, IA or IB to Directive 98/8/EC, concerns as referred to in Article 10(5) of that Directive remain, it should be possible for the Commission to take into account, but without prejudice to Article 12 of that Directive, the finalisation of the evaluation on other existing active substances applied for the same use. Provision should be made for Rapporteur Member States to update competent authority reports where necessary.
(22)
In order to ensure better access to information, assessment reports should be drafted on the basis of the reports submitted by the competent authorities of the Member States and should be covered by the same rules regarding access to information as the reports of the competent authorities. The assessment reports should be derived from the original competent authority report as amended in the light of all the documents, comments and information taken into account during the evaluation process.
(23)
It should be possible to suspend the procedures provided for in this Regulation in the light of the application of other Community acts, in particular as regards Council Directive 76/769/EEC of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (4), and after 1 June 2009, as regards Title VIII and Annex XVII of Regulation (EC) No 1907/2006.
(24)
In order to ensure the most efficient course of the review programme, a number of active substance/product type combinations have been reassigned to different rapporteur Member States. These developments should be reflected in Annex II of this Regulation.
(25)
Regulation (EC) No 2032/2003 has been amended on several occasions (5) in order to take into consideration the accession of new Member States, lessons learned from the implementation to date of the review programme, and in particular in order to provide for the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of a number of active substances, either because the requisite information was not submitted within the prescribed period or in cases where the requirements of Article 10 of the said Directive were not satisfied. This practice of constantly updating Regulation (EC) No 2032/2003 in order to follow the evolution of the review programme has proven ineffectual and time-consuming; furthermore it could create confusion to stakeholders as to which rules apply and which active substances are currently under review. In the interest of clarity, it is preferable to repeal and replace Regulation (EC) No 2032/2003 by a new simplified act which will lay down the rules for the review programme, and that the Commission should adopt separate acts for the future non-inclusion decisions.
(26)
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS REGULATION:
Article 1
Subject matter
This Regulation lays down detailed rules for the implementation of the programme of work for the systematic examination of all active substances already on the market on 14 May 2000 as active substances of biocidal products, hereinafter ‘the review programme’, referred to in Article 16(2) of Directive 98/8/EC.
Article 2
Loading citations...Definitions
For the purposes of this Regulation the definitions in Article 2 of Directive 98/8/EC and Article 2 of Regulation (EC) No 1896/2000 shall apply.
In addition, ‘participant’ means a producer, formulator or association which has submitted a notification that has been accepted by the Commission in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or a Member State which has indicated an interest in accordance with Article 5(3) of that Regulation.
Article 3
Existing active substances
1. The list of active substances identified as available on the market before 14 May 2000 as active substances of biocidal products for purposes other than those referred to in Article 2(2)(c) and (d) of Directive 98/8/EC is set out in Annex I.
2. The exhaustive list of existing active substances to be examined under the review programme is set out in Annex II.
The list includes the following active substances:
(a)
existing active substances notified in accordance with Article 4(1) of Regulation (EC) No 1896/2000 or Article 4(2) of Commission Regulation (EC) No 1687/2002 (6);
(b)
existing active substances that were not notified, but in respect of which a Member State has indicated an interest in supporting their inclusion in Annex I, IA or IB to Directive 98/8/EC;
(c)
existing active substances that were not notified, but for which a dossier was submitted to one of the Member States by 1 March 2006, which was found to comply with the requirements of Annex III to this Regulation and was accepted as complete.
The list specifies, for each existing active substance included, the product types in respect of which the substance will be examined under the review programme, as well as the Rapporteur Member State designated to carry out the evaluation.
Article 4
Non-inclusion
1. Without prejudice to Articles 5 and 6 of this Regulation and paragraph 2 of this Article, biocidal products containing active substances not listed in Annex II to this Regulation or in Annex I or IA to Directive 98/8/EC shall no longer be placed on the market.
In the case of an active substance listed in Annex II to this Regulation, the first subparagraph shall also apply to that substance in relation to any product type not listed in that Annex.
2. Biocidal products containing active substances listed in Annex II to this Regulation for which a decision was taken not to include these active substances for certain or all of their notified product types in Annex I or IA to Directive 98/8/EC, shall no longer be placed on the market for the product types concerned, with effect from 12 months after the date of such a measure being published, unless otherwise stipulated therein.
3. Without prejudice to Articles 12(1)(b) and 15(2) of Directive 98/8/EC, from the day of entry into force of this Regulation, any active substance not listed in Annex I shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.
Article 5
Derogation for essential use
1. Member States may apply to the Commission for a derogation from Article 4(1) where they consider that an active substance is essential for them for reasons of health, safety or protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.
Applications shall be accompanied by a document stating the reasons and justifications.
2. The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and shall be made publicly available by electronic means.
Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission.
3. Taking account of the comments received, the Commission may grant a derogation from Article 4(1) allowing the placing of the substance on the market of the requesting Member States until 14 May 2010 at the latest, provided that the Member States:
(a)
ensure that continued use is possible only if products containing the substance are approved for the intended essential use;
(b)
conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;
(c)
impose all appropriate risk reduction measures when granting approval;
(d)
ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and
(e)
ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.
4. The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e).
5. Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3. Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned.
Article 6
Food and Feed
By way of derogating from Article 4(1), Member States may allow until 14 May 2010 at the latest the placing on the market of active substances consisting solely of food or feed that are intended for use as repellents or attractants of product type 19.
For the purposes of this derogation, ‘food or feed’ means any edible substance or product of plant or animal origin, whether processed, partially processed or unprocessed, which is intended or reasonably expected to be ingested by humans or animals; this category does not comprise extracts or individual substances isolated from food or feed.
Article 7
Examination of existing active substances under the review programme
1. The review of an active substance listed in Annex II, in respect of the product types specified, shall be undertaken by the Rapporteur Member State designated for that purpose on the basis of the complete dossier for that substance/product type combination, provided that:
(a)
the dossier complies with the requirements set out in Annex III to this Regulation;
(b)
the complete dossier is submitted within the period specified in Article 9 of this Regulation for the product type concerned, together with the summary dossier referred to in Article 11(1)(b) of Directive 98/8/EC and defined in Annex III to this Regulation.
An active substance listed in Annex II to this Regulation shall be reviewed exclusively in relation to the product types specified therein.
For the active substance/product type combinations referred to in Article 3(2)(c), with the exception of product types 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for active substances contained in the same product types.
2. A Member State which has indicated an interest in supporting the inclusion of an active substance in Annex I, IA or IB to the Directive shall not be designated as Rapporteur Member State in respect of that substance.
3. Without prejudice to Articles 10, 11 and 12 of this Regulation, persons other than participants may apply, in accordance with Article 11 of Directive 98/8/EC, for the inclusion in Annex I, IA or IB thereto of an existing active substance/product type combination that is listed in Annex II to this Regulation. These persons shall submit in that case a complete dossier within the time period specified in Article 9 for that substance/product type combination.
Article 8
Preparation of the complete dossier
1. In the preparation of the complete dossier, all reasonable efforts shall be made, inter alia, to avoid duplication of testing on vertebrate animals and, where appropriate, to establish a collective complete dossier.
2. Before commencing compilation of the complete dossier, a participant shall:
(a)
inform the Rapporteur Member State of any testing on vertebrate animals that it has already carried out;
(b)
contact the Rapporteur Member State for advice as to the acceptability of justifications for waiving certain studies;
(c)
inform the Rapporteur Member State of any intention to carry out further testing on vertebrate animals for the purposes of the complete dossier;
(d)
when informed by the Rapporteur Member State that another participant has notified plans to carry out the same tests, make all reasonable efforts to cooperate with that participant in the performance of common testing.
Advice given by Rapporteur Member States in accordance with point (b) of the first subparagraph shall not predetermine the outcome of the completeness check under Article 13(1).
3. A Rapporteur Member State may make available the reference to any test carried out on vertebrate animals in respect of an active substance listed in Annex II to this Regulation, save where that reference is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC. Such reference may include the name of the active substance concerned, the end points of the tests, and the contact address of the data owner.
4. Where a Rapporteur Member State is aware that more than one participant is seeking review of a particular active substance, it shall inform those participants accordingly.
5. Participants seeking review of the same active substance for the same product types shall undertake all reasonable efforts to submit a collective complete dossier, while fully respecting the Community rules on competition.
Where, in those circumstances, a collective dossier is not submitted, each individual dossier shall detail the efforts made to secure cooperation and the reasons for non-participation.
6. Details shall be given in the complete dossier and in the summary dossier of the efforts made to avoid duplication of testing on vertebrate animals.
7. In order to provide information on the costs entailed in applying for review and on the need for animal testing for the purposes of compiling the complete dossier, participants may submit to the Rapporteur Member State together with the complete dossiers a breakdown of the costs of the respective actions and studies carried out.
The Rapporteur Member State shall communicate that information to the Commission when submitting the competent authority report in accordance with Article 14(4).
8. Information on the costs entailed in compiling the complete dossier and on the animal testing carried out for that purpose shall be included in the report referred to in Article 18(5) of Directive 98/8/EC together with any appropriate recommendations concerning modifications of data requirements in order to reduce to a minimum the need for testing on vertebrate animals, and to ensure cost-effectiveness and proportionality.
Article 9
Submission of the complete dossier
1. Unless otherwise indicated by the Rapporteur Member State, a participant shall submit to the Rapporteur Member State one paper and one electronic copy of the complete dossier.
The participant shall also, in accordance with Article 13(3), submit one paper and one electronic copy of the summary dossier to the Commission and to each of the other Member States. However, any Member State wishing to receive copies only in electronic format or additional copies shall inform the Commission, which shall make that information publicly available by electronic means. If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.
2. For the existing active substances listed in Annex II, complete dossiers must be received by the competent authority of the Rapporteur Member State within the following periods:
(a)
for product types 8 and 14, until 28 March 2004;
(b)
for product types 16, 18, 19 and 21, from 1 November 2005 until 30 April 2006;
(c)
for product types 1, 2, 3, 4, 5, 6 and 13, from 1 February 2007 until 31 July 2007;
(d)
for product types 7, 9, 10, 11, 12, 15, 17, 20, 22 and 23, from 1 May 2008 until 31 October 2008.
Article 10
Joining and replacing of participants
Where, by mutual agreement, a producer, formulator or association joins or replaces a participant for the purposes of submitting the complete dossier, all parties to the agreement shall jointly inform the Commission and the Rapporteur Member State accordingly, attaching any relevant letter of access.
The Commission shall inform accordingly any other participant seeking review of the same active substance in relation to the same product types.
Article 11
Withdrawal of participants
1. Where a participant intends to discontinue participation in the review programme, they shall inform the relevant Rapporteur Member State and the Commission accordingly, in writing and without delay, stating the reasons.
The Commission shall inform accordingly the other Member States and any other participant seeking review of the same active substance in relation to the same product type(s).
2. Where all the participants have withdrawn as regards a particular existing active substance/product type combination, the Commission shall inform the Member States thereof and shall publish that information electronically.
Article 12
Taking over the role of participant
1. Within three months of the electronic publication of the information referred to in Article 11(2), a producer, formulator, association or other person may inform the Commission of their intention to take over the role of participant as regards the existing active substance/product type combination.
Within the time period referred to in the first subparagraph, a Member State may also indicate to the Commission an interest in taking over the role of participant in order to support the inclusion in Annex I, IA or IB to Directive 98/8/EC of the existing active substance/product type combination, where there are uses which the Member State considers essential, in particular for the protection of human health, animal health or the environment.
2. The person or Member State wishing to take over the role of the participant who has withdrawn shall, within three months of informing the Commission of their intention, provide evidence to it that work to compile a complete dossier has been commissioned.
3. On the basis of the evidence referred to in paragraph 2, the Commission shall decide whether or not to allow the interested person or Member State to take over the role of participant.
Where the Commission allows the interested person or Member State to take over the role of participant, it may decide to extend, if necessary, the relevant period for the submission of a complete dossier specified in Article 9.
4. The taking over of the role of participant for a given existing active substance/product type combination may be allowed only once.
5. Where the Commission receives no response pursuant to paragraph 1, it shall take a decision not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme for the product type(s) concerned.
Article 13
Completeness check of dossiers
1. Within three months of receiving the dossier for an existing active substance/product type combination and no later than three months after the end of the relevant time period specified in Article 9(2) of this Regulation, the Rapporteur Member State shall verify whether the dossier is to be accepted as complete in accordance with Article 11(1)(b) of Directive 98/8/EC.
Where the Rapporteur Member State has initiated consultations with other Member States and the Commission in relation to the acceptability of a dossier, the period may be prolonged until consultations have been finalised, up to a maximum of six months from receipt of the dossier.
2. A Rapporteur Member State may require, as a condition for considering a dossier to be complete, proof of advance payment, in full or in part, of the charges payable under Article 25 of Directive 98/8/EC to be provided in the dossier.
3. Where a dossier is considered to be complete, the Rapporteur Member State shall confirm acceptance of the dossier to the participant and agree to the participant forwarding the summary dossier to the Commission and the other Member States within one month of receiving the confirmation.
If a Member State in receipt of a summary dossier has legitimate reason to believe that the dossier is incomplete, it shall without delay communicate its concerns to the Rapporteur Member State, the Commission and the other Member States.
The Rapporteur Member State shall immediately take up consultations with that Member State and the Commission in order to discuss the concern expressed and resolve divergent opinions.
4. In exceptional circumstances, the Rapporteur Member State may establish a new deadline for the submission of information which, for reasons duly substantiated, the participant was unable to submit in due time.
The participant shall, within three months of being informed of the new deadline, provide evidence to the Rapporteur Member State that work to provide the missing information has been commissioned.
If the Rapporteur Member State considers that it has received sufficient evidence, it shall carry out its evaluation in accordance with Article 14 as if the dossier were complete. Otherwise, the evaluation shall not commence until the missing information is submitted.
5. Where a complete dossier is not received within the period specified in Article 9 or by a new deadline established in accordance with paragraph 4, the Rapporteur Member State shall inform the Commission, giving the reasons put forward by the participant by way of justification.
The Rapporteur Member State shall also inform the Commission in cases where a participant fails to provide the evidence required in accordance with the second subparagraph of paragraph 4. In the cases referred to in the first and second subparagraphs and if no other dossier concerns the same existing active substance/product type combination, all participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis.
Article 14
Evaluation of dossiers by the Rapporteur Member State
1. Where the Rapporteur Member State considers a dossier to be complete, it shall carry out the evaluation within twelve months of accepting the dossier in accordance with Article 11(2) of Directive 98/8/EC and shall prepare a report on that evaluation, hereinafter ‘the competent authority report’.
Without prejudice to Article 12 of Directive 98/8/EC, the Rapporteur Member State may take into account other relevant technical or scientific information regarding the properties of the active substance, metabolites or residues.
2. At the request of a participant, the Rapporteur Member State may take into account additional information relating to an active substance for which the dossier has been accepted as complete only if the following conditions are fulfilled:
(a)
the participant informed the Rapporteur Member State, at the time of submission of the dossier, that preparation of the additional information was under way;
(b)
the additional information is submitted no later than nine months after acceptance of the dossier in accordance with Article 13(3);
(c)
by comparison with the data originally submitted, the additional information is equally or more reliable owing to the application of the same or higher quality standards;
(d)
by comparison with the data originally submitted, the additional information supports a different conclusion concerning the active substance for the purposes of the recommendation under paragraph 6.
The Rapporteur Member State shall take into account additional information submitted by persons other than the participant only if that information satisfies the conditions set out in points (b), (c) and (d) of the first subparagraph.
3. Where relevant in the application of paragraph 1, in particular when additional information has been requested by a deadline established by the Rapporteur Member State, the latter may request that the participant submit updated summary dossiers to the Commission and the other Member States when the additional information is received.
All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:
(a)
the additional information is not received by the deadline;
(b)
the participant fails to provide adequate justification for further postponing the deadline;
(c)
no other dossier concerns the same existing active substance/product type combination.
4. The Rapporteur Member State shall, without undue delay, send a copy of the competent authority report to the Commission, the other Member States and to the participant.
5. A Rapporteur Member State may decide to withhold the competent authority report if the charges payable under Article 25 of Directive 98/8/EC have not been paid in full, in which case it shall inform the participant and the Commission accordingly.
All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:
(a)
full payment is not received within three months of the date of receipt of that information;
(b)
no other dossier concerns the same existing active substance/product type combination.
6. The competent authority report shall be presented in a format to be recommended by the Commission and shall include one of the following:
(a)
a recommendation to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating, where appropriate, conditions for inclusion;
(b)
a recommendation not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating the reasons.
Article 15
Commission procedures
1. When the Commission receives a competent authority report pursuant to Article 14(4) of this Regulation it shall, without undue delay, prepare the draft decision referred to in Article 27 of Directive 98/8/EC.
2. Before preparing the draft decision referred to in paragraph 1, the Commission shall, when necessary in the light of the comments received on the competent authority report, consult with experts from the Member States to address any problems remaining unresolved. Where necessary and upon a request from the Commission, the Rapporteur Member State shall prepare an updated competent authority report.
3. Where an existing active substance, despite a recommendation for inclusion pursuant to Article 14(6) of this Regulation, still gives rise to concern, as referred to in Article 10(5) of Directive 98/8/EC, the Commission may, without prejudice to Article 12 of that Directive, take into account the finalisation of the evaluation of other existing active substances applied for the same use.
4. On the basis of the documents and information referred to in Article 27(2) of Directive 98/8/EC, the Rapporteur Member State shall prepare an updated competent authority report, the first part of which shall form the assessment report. The assessment report shall be reviewed within the Standing Committee on Biocidal Products. Where several dossiers have been submitted for the same active substance/product type combination, the Rapporteur Member State shall prepare one assessment report based on the information contained in those dossiers.
Article 16
Access to information
Where a Rapporteur Member State has submitted the competent authority report in accordance with Article 14(4) of this Regulation, or where an assessment report has been finalised or updated in the Standing Committee on Biocidal Products, the Commission shall make the report or any updates thereof publicly available by electronic means, except for information that is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC.
Article 17
Suspension of procedures
Where, in respect of an active substance listed in Annex II to this Regulation, the Commission presents a proposal for amending Directive 76/769/EEC or, with effect from 1 June 2009, Annex XVII of Regulation (EC) No 1907/2006 in order to prohibit its placing on the market or its use, including use for biocidal purposes, in certain or all product types, the procedures provided for in this Regulation concerning that substance for use in the product types concerned may be suspended pending a decision on that proposal.
Article 18
Repeal
Regulation (EC) No 2032/2003 is repealed.
References to the repealed Regulation shall be construed as references to this Regulation.
Article 19
Entry into force
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 4 December 2007.
For the Commission
Stavros DIMAS
Member of the Commission
(1) OJ L 123, 24.4.1998, p. 1. Directive as last amended by Directive 2007/47/EC (OJ L 247, 21.9.2007, p. 21).
(2) OJ L 228, 8.9.2000, p. 6. Regulation as amended by Regulation (EC) No 2032/2003 (OJ L 307, 24.11.2003, p. 1).
(3) OJ L 307, 24.11.2003, p. 1. Regulation as last amended by Regulation (EC) No 1849/2006 (OJ L 355, 15.12.2006, p. 63).
(4) OJ L 262, 27.9.1976, p. 201. Directive as last amended by Directive 2007/51/EC of the European Parliament and of the Council (OJ L 257, 3.10.2007, p. 13).
(5) By Regulation (EC) No 1048/2005 (OJ L 178, 9.7.2005, p. 1); and Regulation (EC) No 1849/2006, (OJ L 355, 15.12.2006, p. 63).
(6) OJ L 258, 26.9.2002, p. 15.
ANNEX I
ACTIVE SUBSTANCES IDENTIFIED AS EXISTING
Name (EINECS and/or others)
EC number
CAS number
Formaldehyde
200-001-8
50-00-0
Ergocalciferol/Vitamin D2
200-014-9
50-14-6
Lactic acid
200-018-0
50-21-5
Clofenotane/DDT
200-024-3
50-29-3
Ascorbic acid
200-066-2
50-81-7
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide
200-076-7
51-03-6
2,4-dinitrophenol
200-087-7
51-28-5
2-imidazol-4-ylethylamine
200-100-6
51-45-6
Bronopol
200-143-0
52-51-7
Trichlorfon
200-149-3
52-68-6
Sodium salicylate
200-198-0
54-21-7
Fenthion
200-231-9
55-38-9
Glycerol trinitrate
200-240-8
55-63-0
Bis(tributyltin) oxide
200-268-0
56-35-9
Tributyltin acetate
200-269-6
56-36-0
Coumaphos
200-285-3
56-72-4
Glycerol
200-289-5
56-81-5
Chlorhexidine diacetate
200-302-4
56-95-1
Allyl isothiocyanate
200-309-2
57-06-7
Cetrimonium bromide/Hexadecyltrimethylammonium bromide
200-311-3
57-09-0
Urea
200-315-5
57-13-6
Strychnine
200-319-7
57-24-9
Propane-1,2-diol
200-338-0
57-55-6
Ethinylestradiol
200-342-2
57-63-6
Caffeine
200-362-1
58-08-2
Diphenoxarsin-10-yl oxide
200-377-3
58-36-6
Gamma-HCH or Gamma-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane
200-401-2
58-89-9
Sulfaquinoxaline
200-423-2
59-40-5
Chlorocresol
200-431-6
59-50-7
2-phenylethanol
200-456-2
60-12-8
Dimethoate
200-480-3
60-51-5
Methylthioninium chloride
200-515-2
61-73-4
Thiourea
200-543-5
62-56-6
Dichlorvos
200-547-7
62-73-7
Carbaryl
200-555-0
63-25-2
Ethanol
200-578-6
64-17-5
Formic acid
200-579-1
64-18-6
Acetic acid
200-580-7
64-19-7
Benzoic acid
200-618-2
65-85-0
Propan-2-ol
200-661-7
67-63-0
Chloroform/Trichloromethane
200-663-8
67-66-3
Colecalciferol
200-673-2
67-97-0
Salicylic acid
200-712-3
69-72-7
Hexachlorophene
200-733-8
70-30-4
Propan-1-ol
200-746-9
71-23-8
Butan-1-ol
200-751-6
71-36-3
Methoxychlor
200-779-9
72-43-5
Bromomethane/Methyl bromide
200-813-2
74-83-9
Hydrogen cyanide
200-821-6
74-90-8
Metaldehyde
200-836-8
9002-91-9
Carbon disulfide
200-843-6
75-15-0
Ethylene oxide
200-849-9
75-21-8
Iodoform/Triiodomethane
200-874-5
75-47-8
Tert-butyl hydroperoxide
200-915-7
75-91-2
Trichloronitromethane
200-930-9
76-06-2
Bornan-2-one/Campher
200-945-0
76-22-2
(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione/Quassin
200-985-9
76-78-8
1,3-dibromo-5,5-dimethylhydantoin
201-030-9
77-48-5
3-beta-hydroxyurs-12-en-28-oic acid/Ursolic acid
201-034-0
77-52-1
Citric acid
201-069-1
77-92-9
Citric acid monohydrate
201-069-1
5949-29-1
1,3,4,5-tetrahydroxycyclohexanecarboxylic acid
201-072-8
77-95-2
Linalool
201-134-4
78-70-6
2-methylpropan-1-ol
201-148-0
78-83-1
2-chloroacetamide
201-174-2
79-07-2
Bromoacetic acid
201-175-8
79-08-3
Propionic acid
201-176-3
79-09-4
Chloroacetic acid
201-178-4
79-11-8
Glycollic acid
201-180-5
79-14-1
Peracetic acid
201-186-8
79-21-0
L-(+)-lactic acid
201-196-2
79-33-4
p-(1,1-dimethylpropyl)phenol
201-280-9
80-46-6
Pin-2(3)-ene
201-291-9
80-56-8
Sennoside A
201-339-9
81-27-6
Warfarin
201-377-6
81-81-2
Coumachlor
201-378-1
81-82-3
Diphacinone
201-434-5
82-66-6
Ethyl quinine carbonate
201-500-3
83-75-0
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone
201-501-9
83-79-4
Anthraquinone
201-549-0
84-65-1
Dibutyl phthalate
201-557-4
84-74-2
Salicylanilide
201-727-8
87-17-2
(+)-tartaric acid
201-766-0
87-69-4
Pentachlorophenol
201-778-6
87-86-5
Symclosene
201-782-8
87-90-1
Chloroxylenol
201-793-8
88-04-0
2,4,6-trichlorophenol
201-795-9
88-06-2
Menthol
201-939-0
89-78-1
Isopulegol
201-940-6
89-79-2
Thymol
201-944-8
89-83-8
Guaiacol/2-methoxyphenol
201-964-7
90-05-1
Biphenyl-2-ol
201-993-5
90-43-7
Naphthalene
202-049-5
91-20-3
Propyl 4-hydroxybenzoate
202-307-7
94-13-3
Butyl 4-hydroxybenzoate
202-318-7
94-26-8
Dibenzoyl peroxide
202-327-6
94-36-0
2-ethylhexane-1,3-diol
202-377-9
94-96-2
Benzotriazole
202-394-1
95-14-7
3-chloropropane-1,2-diol
202-492-4
96-24-2
Dichlorophen
202-567-1
97-23-4
Eugenol
202-589-1
97-53-0
Allantoin
202-592-8
97-59-6
Methyl 4-hydroxybenzoate
202-785-7
99-76-3
Benzyl alcohol
202-859-9
100-51-6
2,2′-[(1,1,3-trimethylpropane-1,3-diyl)bis(oxy)]bis[4,4,6-trimethyl-1,3,2-dioxaborinane]
202-899-7
100-89-0
Methenamine/Hexamethylenetetramine
202-905-8
100-97-0
Triclocarban
202-924-1
101-20-2
Chlorpropham
202-925-7
101-21-3
1,1′,1″,1‴!-ethylenedinitrilotetrapropan-2-ol
203-041-4
102-60-3
2,2′,2″-nitrilotriethanol
203-049-8
102-71-6
Chlorphenesin
203-192-6
104-29-0
Anethole
203-205-5
104-46-1
Cinnamaldehyde/3-phenyl-propen-2-al
203-213-9
104-55-2
2-ethylhexan-1-ol/Isooctanol
203-234-3
104-76-7
Citronellol
203-375-0
106-22-9
Citronellal
203-376-6
106-23-0
Geraniol
203-377-1
106-24-1
1,4-dichlorobenzene
203-400-5
106-46-7
Ethylendiamine
203-468-6
107-15-3
Chloro-acetaldehyde
203-472-8
107-20-0
Ethane-1,2-diol
203-473-3
107-21-1
Glyoxal
203-474-9
107-22-2
Methyl formate
203-481-7
107-31-3
Butane-1,3-diol
203-529-7
107-88-0
Vinyl acetate
203-545-4
108-05-4
Acetic anhydride
203-564-8
108-24-7
m-Cresol
203-577-9
108-39-4
Resorcinol
203-585-2
108-46-3
Cyanuric acid
203-618-0
108-80-5
Phenol
203-632-7
108-95-2
Ethyl formate
203-721-0
109-94-4
Succinic acid
203-740-4
110-15-6
Hexa-2,4-dienoic acid/Sorbic acid
203-768-7
110-44-1
Pyridine
203-809-9
110-86-1
Morpholine
203-815-1
110-91-8
Glutaral
203-856-5
111-30-8
2-Butoxyethanol
203-905-0
111-76-2
Cetrimonium chloride/Hexadecyl-trimethylammoniumchloride
203-928-6
112-02-7
Nonanoic acid
203-931-2
112-05-0
Undecan-2-one/Methyl-nonyl-ketone
203-937-5
112-12-9
2,2′-(ethylenedioxy)diethanol/Triethylene-glycol
203-953-2
112-27-6
Undec-10-enoic acid
203-965-8
112-38-9
Oleic acid
204-007-1
112-80-1
(Z)-docos-13-enoic acid
204-011-3
112-86-7
N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide
204-029-1
113-48-4
Propoxur
204-043-8
114-26-1
Endosulfan
204-079-4
115-29-7
1,7,7-trimethylbicyclo[2.2.1]hept-2-yl thiocyanatoacetate
204-081-5
115-31-1
Dicofol
204-082-0
115-32-2
Linalyl acetate
204-116-4
115-95-7
3,3′,4′,5,7-pentahydroxyflavone
204-187-1
117-39-5
1,3-dichloro-5,5-dimethylhydantoin
204-258-7
118-52-5
Methyl salicylate
204-317-7
119-36-8
Clorophene
204-385-8
120-32-1
Ethyl 4-hydroxybenzoate
204-399-4
120-47-8
Benzyl benzoate
204-402-9
120-51-4
Piperonal
204-409-7
120-57-0
Indole
204-420-7
120-72-9
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-cyclopropanecarboxylate/Cinerin II
204-454-2
121-20-0
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)],3.beta.]]-chrysanthemate/Pyrethrin I
204-455-8
121-21-1
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)](3.beta.)-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate/Pyrethrin II
204-462-6
121-29-9
Benzethonium chloride
204-479-9
121-54-0
5-nitrothiazol-2-ylamine
204-490-9
121-66-4
Malathion
204-497-7
121-75-5
Fenitrothion
204-524-2
122-14-5
Cetalkonium chloride
204-526-3
122-18-9
Benzyldimethyl(octadecyl)ammonium chloride
204-527-9
122-19-0
Simazine
204-535-2
122-34-9
Propham
204-542-0
122-42-9
4-Phenylbutanone
204-555-1
122-57-6
2-Phenoxyethanol
204-589-7
122-99-6
Cetylpyridinium chloride
204-593-9
123-03-5
Cetylpyridinium chloride monohydrate
204-593-9
6004-24-6
2-Ethylhexanal
204-596-5
123-05-7
Pyridazine-3,6-diol/Maleic hydrazide
204-619-9
123-33-1
Adipic acid
204-673-3
124-04-9
Octanoic acid
204-677-5
124-07-2
Dodecylamine/Laurylamine
204-690-6
124-22-1
Carbon dioxide
204-696-9
124-38-9
Sodium dimethylarsinate
204-708-2
124-65-2
Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol
204-712-4
124-76-5
Nitromethylidynetrimethanol
204-769-5
126-11-4
Sodium acetate
204-823-8
127-09-3
Sodium N-chlorobenzenesulphonamide
204-847-9
127-52-6
Tosylchloramide sodium
204-854-7
127-65-1
Bis(2,3,3,3-tetrachloropropyl) ether
204-870-4
127-90-2
Potassium dimethyldithiocarbamate
204-875-1
128-03-0
Sodium dimethyldithiocarbamate
204-876-7
128-04-1
N-bromosuccinimide
204-877-2
128-08-5
N-chlorosuccinimide
204-878-8
128-09-6
2,6-di-tert-butyl-p-cresol
204-881-4
128-37-0
Warfarin sodium
204-929-4
129-06-6
Dimethyl phthalate
205-011-6
131-11-3
Sodium pentachlorophenolate
205-025-2
131-52-2
Sodium 2-biphenylate
205-055-6
132-27-4
Sodium 2-biphenylate tetrahydrate
205-055-6
6152-33-6
Captan
205-087-0
133-06-2
N-(trichloromethylthio)phthalimide/Folpet
205-088-6
133-07-3
2,4-Dichloro-3,5-xylenol
205-109-9
133-53-9
Methyl anthranilate
205-132-4
134-20-3
Bis(8-hydroxyquinolinium) sulphate
205-137-1
134-31-6
N,N-diethyl-m-toluamide
205-149-7
134-62-3
Dipropyl pyridine-2,5-dicarboxylate
205-245-9
136-45-8
Zinc bis(2-ethylhexanoate)
205-251-1
136-53-8
6-methylbenzotriazole
205-265-8
136-85-6
Thiram
205-286-2
137-26-8
Ziram
205-288-3
137-30-4
Sodium propionate
205-290-4
137-40-6
Potassium methyldithiocarbamate
205-292-5
137-41-7
Metam-sodium
205-293-0
137-42-8
Dipentene
205-341-0
138-86-3
Disodium cyanodithiocarbamate
205-346-8
138-93-2
Benzododecinium chloride
205-351-5
139-07-1
Miristalkonium chloride
205-352-0
139-08-2
Nitrilo triacetic acid
205-355-7
139-13-9
p-tolyl acetate
205-413-1
140-39-6
1,3-bis(hydroxymethyl)urea
205-444-0
140-95-4
Sodium formate
205-488-0
141-53-7
2,3-dihydroxypropyl laurate
205-526-6
142-18-7
Nabam
205-547-0
142-59-6
Hexanoic acid
205-550-7
142-62-1
Lauric acid
205-582-1
143-07-7
Potassium oleate
205-590-5
143-18-0
Sodium hydrogencarbonate
205-633-8
144-55-8
Oxalic acid
205-634-3
144-62-7
Quinolin-8-ol
205-711-1
148-24-3
Thiabendazole
205-725-8
148-79-8
Benzothiazole-2-thiol
205-736-8
149-30-4
Monuron
205-766-1
150-68-5
Rutoside
205-814-1
153-18-4
Glyoxylic acid
206-058-5
298-12-4
Fenchlorphos
206-082-6
299-84-3
Naled
206-098-3
300-76-5
5-chlorosalicylic acid
206-283-9
321-14-2
Diuron
206-354-4
330-54-1
Potassium thiocyanate
206-370-1
333-20-0
Diazinon
206-373-8
333-41-5
Decanoic acid
206-376-4
334-48-5
Cyanamide
206-992-3
420-04-2
Metronidazole
207-136-1
443-48-1
Cineole
207-431-5
470-82-6
7,8-dihydroxycoumarin
207-632-8
486-35-1
Sodium carbonate
207-838-8
497-19-8
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one
207-880-7
499-44-5
Carvacrol
207-889-6
499-75-2
6.beta.-acetoxy-3beta-(beta.-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide/Scilliroside
208-077-4
507-60-8
Barium carbonate
208-167-3
513-77-9
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione
208-293-9
520-45-6
Osalmid
208-385-9
526-18-1
2,6-Dimethoxy-p-benzoquinone
208-484-7
530-55-2
Acridine-3,6-diamine dihydrochloride
208-515-4
531-73-7
Sodium benzoate
208-534-8
532-32-1
Dazomet
208-576-7
533-74-4
Trisodium hydrogendicarbonate/Sodium sesquicarbonate
208-580-9
533-96-0
Silver carbonate
208-590-3
534-16-7
Crimidine
208-622-6
535-89-7
Calcium diformate
208-863-7
544-17-2
Myristic acid
208-875-2
544-63-8
1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one
208-912-2
546-80-5
1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione/Hypericum perforatum
208-941-0
548-04-9
[4-[4,4′-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6
548-62-9
Zinc dibenzoate
209-047-3
553-72-0
Methyl isothiocyanate
209-132-5
556-61-6
4,4′-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride
209-321-2
569-61-9
[4-[alpha-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride/Malachite green chloride
209-322-8
569-64-2
Potassium benzoate
209-481-3
582-25-2
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/Allethrin
209-542-4
584-79-2
Sodium 3-(p-anilinophenylazo)benzenesulphonate/Metanil yellow
209-608-2
587-98-4
DL-lactic acid
209-954-4
598-82-3
BHC or HCH/Hexachlorocyclohexane
210-168-9
608-73-1
DL-malic acid
210-514-9
617-48-1
N-(hydroxymethyl)acetamide
210-897-2
625-51-4
Succinaldehyde
211-333-8
638-37-9
2-fluoroacetamide
211-363-1
640-19-7
Phthalaldehyde
211-402-2
643-79-8
2-hydroxyethanesulphonic acid, compound with 4,4′-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1)
211-533-5
659-40-5
Tetrahydro-2,5-dimethoxyfuran
211-797-1
696-59-3
N-[(dichlorofluoromethyl)thio]phthalimide
211-952-3
719-96-0
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid
211-986-9
731-27-1
Levonorgestrel
212-349-8
797-63-7
Hydroxyl-2-pyridone
212-506-0
822-89-9
2,6-dimethyl-1,3-dioxan-4-yl acetate
212-579-9
828-00-2
Terbutryn
212-950-5
886-50-0
Proflavine hydrochloride
213-459-9
952-23-8
N′1-quinoxalin-2-ylsulphanilamide, sodium salt
213-526-2
967-80-6
Norbormide
213-589-6
991-42-4
(hydroxymethyl)urea
213-674-8
1000-82-4
Dichlofluanid
214-118-7
1085-98-9
Copper thiocyanate
214-183-1
1111-67-7
Dodecyltrimethylammonium bromide
214-290-3
1119-94-4
Tetradonium bromide
214-291-9
1119-97-7
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin
214-619-0
1166-46-7
4,5-dichloro-3H-1,2-dithiol-3-one
214-754-5
1192-52-5
Xylenol
215-089-3
1300-71-6
Bentonite
215-108-5
1302-78-9
Diarsenic pentaoxide
215-116-9
1303-28-2
Diboron trioxide
215-125-8
1303-86-2
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime
215-137-3
1305-62-0
Calcium oxide/lime/burnt lime/quicklime
215-138-9
1305-78-8
Potassium hydroxide
215-181-3
1310-58-3
Sodium hydroxide
215-185-5
1310-73-2
Silicic acid, potassium salt/Potassium silicate
215-199-1
1312-76-1
Zinc oxide
215-222-5
1314-13-2
Trizinc diphosphide
215-244-5
1314-84-7
Zinc sulphide
215-251-3
1314-98-3
Trimanganese tetraoxide
215-266-5
1317-35-7
Copper oxide
215-269-1
1317-38-0
Dicopper oxide
215-270-7
1317-39-1
Cresol
215-293-2
1319-77-3
Aluminum chloride, basic
215-477-2
1327-41-9
Disodium tetraborate, anhydrous
215-540-4
1330-43-4
Disodium tetraborate decahydrate
215-540-4
1303-96-4
Dicopper chloride trihydroxide
215-572-9
1332-65-6
Chromium trioxide
215-607-8
1333-82-0
Sodium hydrogendifluoride
215-608-3
1333-83-1
Naphthenic acids, copper salts
215-657-0
1338-02-9
2-Butanone, peroxide
215-661-2
1338-23-4
Naphthenic acids
215-662-8
1338-24-5
Ammonium hydrogendifluoride
215-676-4
1341-49-7
Silicic acid, sodium salt
215-687-4
1344-09-8
Copper(II) chloride
215-704-5
1344-67-8
N,N″-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride
216-994-6
1715-30-6
Monolinuron
217-129-5
1746-81-2
2,4-dichlorobenzyl alcohol
217-210-5
1777-82-8
Ethacridine lactate
217-408-1
1837-57-6
4,4′-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine
217-450-0
1854-23-5
Chlorothalonil
217-588-1
1897-45-6
Dodecylammonium acetate
217-956-1
2016-56-0
Fluometuron
218-500-4
2164-17-2
Allyl propyl disulphide
218-550-7
2179-59-1
4-(2-nitrobutyl)morpholine
218-748-3
2224-44-4
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
219-145-8
2372-82-9
Didecyldimethylammonium bromide
219-234-1
2390-68-3
Tolnaftate
219-266-6
2398-96-1
Bis[[4-[4-(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium] oxalate, dioxalate
219-441-7
2437-29-8
Dodine
219-459-5
2439-10-3
2-bromo-1-(4-hydroxyphenyl)ethan-1-one
219-655-0
2491-38-5
2,2′-dithiobis[N-methylbenzamide]
219-768-5
2527-58-4
2,2′-[methylenebis(oxy)]bisethanol
219-891-4
2565-36-8
Phenthoate
219-997-0
2597-03-7
1,2-benzisothiazol-3(2H)-one
220-120-9
2634-33-5
2,2′-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane]
220-198-4
2665-13-6
2-methyl-2H-isothiazol-3-one
220-239-6
2682-20-4
Sulphuryl difluoride
220-281-5
2699-79-8
2-Amino-3-chloro-1,4-naphthoquinone
220-529-2
2797-51-5
2-chloro-N-(hydroxymethyl)acetamide
220-598-9
2832-19-1
Troclosene sodium
220-767-7
2893-78-9
Sodium dichloroisocyanurate dihydrate
220-767-7
51580-86-0
Chlorpyrifos
220-864-4
2921-88-2
Mecetronium ethyl sulphate
221-106-5
3006-10-8
Dodecylethyldimethylammonium ethyl sulphate
221-108-6
3006-13-1
Bis(trichloromethyl) sulphone
221-310-4
3064-70-8
Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate
221-416-0
3088-31-1
4-isopropyl-m-cresol
221-761-7
3228-02-2
Copper dinitrate
221-838-5
3251-23-8
Triclosan
222-182-2
3380-34-5
Temephos
222-191-1
3383-96-8
Thuj-4(10)-ene
222-212-4
3387-41-5
Oct-1-ene-3-ol
222-226-0
3391-86-4
Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate
222-654-8
3567-25-7
(ethylenedioxy)dimethanol
222-720-6
3586-55-8
Chlorophacinone
223-003-0
3691-35-8
Dipyrithione
223-024-5
3696-28-4
Chlorhexidine dihydrochloride
223-026-6
3697-42-5
Denatonium benzoate
223-095-2
3734-33-6
Sodium 2,4,6-trichlorophenolate
223-246-2
3784-03-0
Pyridine-2-thiol 1-oxide, sodium salt
223-296-5
3811-73-2
Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine
223-563-6
3960-05-2
4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid/Tributyltin maleate
223-701-5
4027-18-3
Methenamine 3-chloroallylochloride
223-805-0
4080-31-3
N-ethylheptadecafluorooctanesulphonamide
223-980-3
4151-50-2
Isobutyl 4-hydroxybenzoate/Isobutyl parabene
224-208-8
4247-02-3
Tributylstannyl salicylate/Tributyltin salicylate
224-397-7
4342-30-7
Tributylstannyl benzoate/Tributyltin benzoate
224-399-8
4342-36-3
Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate
224-580-1
4418-26-2
Diethylammonium salicylate
224-586-4
4419-92-5
Dimethyl dicarbonate
224-859-8
4525-33-1
Farnesol
225-004-1
4602-84-0
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol
225-208-0
4719-04-4
Octylphosphonic acid
225-218-5
4724-48-5
Sodium 4-(methoxycarbonyl)phenolate
225-714-1
5026-62-0
Sulphamidic acid
226-218-8
5329-14-6
Citral
226-394-6
5392-40-5
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione
226-408-0
5395-50-6
1-benzyl-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride
226-445-2
5400-93-1
Dimethyldioctylammonium chloride
226-901-0
5538-94-3
N-dodecylpropane-1,3-diamine
226-902-6
5538-95-4
Chlorpyrifos-methyl
227-011-5
5598-13-0
N,N′-methylenebismorpholine
227-062-3
5625-90-1
Coumatetralyl
227-424-0
5836-29-3
Terbuthylazine
227-637-9
5915-41-3
(R)-p-mentha-1,8-diene
227-813-5
5989-27-5
4-methoxybenzene-1,3-diamine sulphate
228-290-6
6219-67-6
Methylene dithiocyanate
228-652-3
6317-18-6
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione
229-222-8
6440-58-0
Dodicin
229-930-7
6843-97-6
Malic acid
230-022-8
6915-15-7
(2-bromo-2-nitrovinyl)benzene
230-515-8
7166-19-0
Didecyldimethylammonium chloride
230-525-2
7173-51-5
(Z)-N-9-octadecenylpropane-1,3-diamine
230-528-9
7173-62-8
Benzyldodecyldimethylammonium bromide
230-698-4
7281-04-1
Prometryn
230-711-3
7287-19-6
Silver
231-131-3
7440-22-4
Boron
231-151-2
7440-42-8
Copper
231-159-6
7440-50-8
Zinc
231-175-3
7440-66-6
Sulphur dioxide
231-195-2
7446-09-5
Dithallium sulphate
231-201-3
7446-18-6
Calcium dihexa-2,4-dienoate
231-321-6
7492-55-9
Quinine monohydrochloride dihydrate
231-437-7
6119-47-7
Iodine
231-442-4
7553-56-2
Iodine in the form of iodophor
Mixture
39392-86-4
Iodine complex in solution with non-ionic detergents
Mixture
Polyvinylpyrrolidone iodine
Polymer
25655-41-8
Alkylaryl polyether alcohol-iodine complex
Polymer
Iodine complex with ethylene-propylene block co-Polymer (pluronic)
Polymer
Iodine complex with poly alkylenglycol
Polymer
Iodinated Resin/Polyiodide Anion Resin
Polymer
Trisodium orthophosphate (TSP)
231-509-8
7601-54-9
Silicon dioxide — amorphous
231-545-4
7631-86-9
Sodium hydrogensulphite
231-548-0
7631-90-5
Sodium nitrite
231-555-9
7632-00-0
Sodium peroxometaborate/Sodium perborate hydrate
231-556-4
7632-04-4
Hydrogen chloride/Hydrochloric acid
231-595-7
7647-01-0
Sodium chloride
231-598-3
7647-14-5
Sodium bromide
231-599-9
7647-15-6
Orthophosphoric acid
231-633-2
7664-38-2
Hydrogen fluoride
231-634-8
7664-39-3
Ammonia, anhydrous
231-635-3
7664-41-7
Sulphuric acid
231-639-5
7664-93-9
Potassium iodide
231-659-4
7681-11-0
Sodium hydrogensulphate
231-665-7
7681-38-1
Sodium fluoride
231-667-8
7681-49-4
Sodium hypochlorite
231-668-3
7681-52-9
Disodium disulphite
231-673-0
7681-57-4
Tetramethrin
231-711-6
7696-12-0
Sulphur
231-722-6
7704-34-9
Iron sulphate
231-753-5
7720-78-7
Iron vitriol/Ferrous sulphate heptahydrate/Iron sulphate heptahydrate
231-753-5
7782-63-0
Potassium permanganate
231-760-3
7722-64-7
Hydrogen peroxide
231-765-0
7722-84-1
Bromine
231-778-1
7726-95-6
Dipotassium peroxodisulphate
231-781-8
7727-21-1
Nitrogen
231-783-9
7727-37-9
Zinc sulphate heptahydrate
231-793-3
7446-20-0
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole
231-810-4
7747-35-5
Sodium sulphite
231-821-4
7757-83-7
Sodium chlorite
231-836-6
7758-19-2
Copper chloride
231-842-9
7758-89-6
Copper sulphate
231-847-6
7758-98-7
Copper sulphate pentahydrate
231-847-6
7758-99-8
Silver nitrate
231-853-9
7761-88-8
Sodium thiosulphate pentahydrate
231-867-5
10102-17-7
Sodium chlorate
231-887-4
7775-09-9
Disodium peroxodisulphate/Sodium persulphate
231-892-1
7775-27-1
Potassium dichromate
231-906-6
7778-50-9
Calcium hypochlorite
231-908-7
7778-54-3
Hexahydro-1,3,5-triethyl-1,3,5-triazine
231-924-4
7779-27-3
Chlorine
231-959-5
7782-50-5
Ammonium sulphate
231-984-1
7783-20-2
Silver chloride
232-033-3
7783-90-6
Aluminium ammonium bis(sulphate)
232-055-3
7784-25-0
Manganese sulphate
232-089-9
7785-87-7
Manganese sulphate tetrahydrate
232-089-9
10101-68-5
Iodine monochloride
232-236-7
7790-99-0
Terpineol
232-268-1
8000-41-7
Soybean oil
232-274-4
8001-22-7
Linseed oil
232-278-6
8001-26-1
Corn oil
232-281-2
8001-30-7
Coconut oil
232-282-8
8001-31-8
Creosote
232-287-5
8001-58-9
Castor oil
232-293-8
8001-79-4
Bone oil/Animal oil
232-294-3
8001-85-2
Rape oil
232-299-0
8002-13-9
Pyrethrins and Pyrethroids
232-319-8
8003-34-7
Terpinol
—
8006-39-1
Turpentine oil
232-350-7
8006-64-2
Garlic ext.
232-371-1
8008-99-9
Tar, pine/Pine wood tar
232-374-8
8011-48-1
Beeswax
232-383-7
8012-89-3
Paraffin oils
232-384-2
8012-95-1
Oils, avocado
232-428-0
8024-32-6
Orange, sweet, ext.
232-433-8
8028-48-6
White mineral oil (petroleum)
232-455-8
8042-47-5
Saponins
232-462-6
8047-15-2
Tall-oil rosin
232-484-6
8052-10-6
Asphalt/Bitumen
232-490-9
8052-42-4
Copals
232-527-9
9000-14-0
Lignin
232-682-2
9005-53-2
Aluminium sulphate
233-135-0
10043-01-3
Boric acid
233-139-2
10043-35-3
Aluminium potassium bis(sulphate)/Alum
233-141-3
10043-67-1
Chlorine dioxide
233-162-8
10049-04-4
Potassium sulphite
233-321-1
10117-38-1
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]
233-457-1
10187-52-7
2,2-dibromo-2-cyanoacetamide
233-539-7
10222-01-2
Disilver(1+) sulphate
233-653-7
10294-26-5
Sodium metaphosphate
233-782-9
10361-03-2
Oxine-copper
233-841-9
10380-28-6
Resmethrin
233-940-7
10453-86-8
N,N′-ethylenebis[N-acetylacetamide]
234-123-8
10543-57-4
Sodium dichromate
234-190-3
10588-01-9
Carbendazim
234-232-0
10605-21-7
Tridecasodium hypochloritetetrakis(phosphate)
234-307-8
11084-85-8
Natural boric acid
234-343-4
11113-50-1
Sodium perborate tetrahydrate
234-390-0
10486-00-7
Perboric acid, sodium salt
234-390-0
11138-47-9
Naphthenic acids, zinc salts
234-409-2
12001-85-3
Disodium octaborate
234-541-0
12008-41-2
Disodium octaborate tetrahydrate
234-541-0
12280-03-4
[2H4]ammonium chloride
234-607-9
12015-14-4
Dialuminium chloride pentahydroxide
234-933-1
12042-91-0
Trimagnesium diphosphide
235-023-7
12057-74-8
Sodium toluenesulphonate
235-088-1
12068-03-0
Copper(II) carbonate-copper(II) hydroxide (1:1)
235-113-6
12069-69-1
Zineb
235-180-1
12122-67-7
Ammonium bromide
235-183-8
12124-97-9
Tetraboron disodium heptaoxide, hydrate
235-541-3
12267-73-1
Maneb
235-654-8
12427-38-2
Hexaboron dizinc undecaoxide/Zinc borate
235-804-2
12767-90-7
N-(hydroxymethyl)formamide
235-938-1
13052-19-2
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-5
13108-52-6
Nifurpirinol
236-503-9
13411-16-0
Pyrithione zinc
236-671-3
13463-41-7
Titanium dioxide
236-675-5
13463-67-7
Dodecylguanidine monohydrochloride
237-030-0
13590-97-1
Barium diboron tetraoxide
237-222-4
13701-59-2
Potassium 2-biphenylate
237-243-9
13707-65-8
Ammonium tetrafluoroborate
237-531-4
13826-83-0
Lithium hypochlorite
237-558-1
13840-33-0
Orthoboric acid, sodium salt
237-560-2
13840-56-7
Bromine chloride
237-601-4
13863-41-7
Zinc bis(diethyldithiocarbamate)
238-270-9
14324-55-1
(benzyloxy)methanol
238-588-8
14548-60-8
2,2′-oxybis[4,4,6-trimethyl-1,3,2-dioxaborinane]
238-749-2
14697-50-8
Phoxim
238-887-3
14816-18-3
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper
238-984-0
14915-37-8
Bis(8-hydroxyquinolyl) sulphate, monopotassium salt
239-133-6
15077-57-3
Dibromopropionamide
239-153-5
15102-42-8
Sodium perborate monohydrate
239-172-9
10332-33-9
2,2′-methylenebis(6-bromo-4-chlorophenol)
239-446-8
15435-29-7
Chlorotoluron
239-592-2
15545-48-9
Disodium carbonate, compound with hydrogen peroxide (2:3)
239-707-6
15630-89-4
Sodium p-chloro-m-cresolate
239-825-8
15733-22-9
Chloralose
240-016-7
15879-93-3
1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione
240-230-0
16079-88-2
(R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-0
16484-77-8
Dipotassium disulphite
240-795-3
16731-55-8
Methomyl
240-815-0
16752-77-5
Disodium hexafluorosilicate
240-934-8
16893-85-9
Hexafluorosilicic acid
241-034-8
16961-83-4
Benomyl
241-775-7
17804-35-2
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)
242-354-0
18472-51-0
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-8
18854-01-8
Benzoxonium chloride
243-008-1
19379-90-9
Methyl hydroxymethoxyacetate
243-271-2
19757-97-2
p-[(diiodomethyl)sulphonyl]toluene
243-468-3
20018-09-1
Copper dihydroxide
243-815-9
20427-59-2
Disilver oxide
243-957-1
20667-12-3
2-butene-1,4-diyl bis(bromoacetate)
243-962-9
20679-58-7
Aluminium phosphide
244-088-0
20859-73-8
(benzothiazol-2-ylthio)methyl thiocyanate
244-445-0
21564-17-0
Tetrachlorvinphos
244-865-4
22248-79-9
Bendiocarb
245-216-8
22781-23-3
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin
245-387-9
23031-36-9
Potassium (E,E)-hexa-2,4-dienoate
246-376-1
24634-61-5
2-tert-Butyl-4-methoxyphenol
246-563-8
25013-16-5
Bis(hydroxymethyl)urea
246-679-9
25155-29-7
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol
246-764-0
25254-50-6
2,2′-(octadec-9-enylimino)bisethanol
246-807-3
25307-17-9
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Cinerin I
246-948-0
25402-06-6
3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate/Phenothrin
247-404-5
26002-80-2
5-chloro-2-methyl-2H-isothiazol-3-one
247-500-7
26172-55-4
2-octyl-2H-isothiazol-3-one
247-761-7
26530-20-1
Dodecylbenzenesulphonic acid
248-289-4
27176-87-0
Lauric acid, monoester with glycerol
248-337-4
27215-38-9
Zinc neodecanoate
248-370-4
27253-29-8
Dodecyl(ethylbenzyl)dimethylammonium chloride
248-486-5
27479-28-3
Cis-tricos-9-ene
248-505-7
27519-02-4
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
248-595-8
27668-52-6
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine
248-872-3
28159-98-0
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin
249-013-5
28434-00-6
Bioresmethrin
249-014-0
28434-01-7
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone
249-205-9
28772-56-7
Pirimiphos-methyl
249-528-5
29232-93-7
Lithium heptadecafluorooctanesulphonate
249-644-6
29457-72-5
5-bromo-5-nitro-1,3-dioxane
250-001-7
30007-47-7
Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate
250-517-2
31218-83-4
(Z,E)-tetradeca-9,12-dienyl acetate
250-753-6
30507-70-1 (1)
Decyldimethyloctylammonium chloride
251-035-5
32426-11-2
Bromochloro-5,5-dimethylimidazolidine-2,4-dione
251-171-5
32718-18-6
Amitraz
251-375-4
33089-61-1
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
251-835-4
34123-59-6
2-(hydroxymethylamino)ethanol
251-974-0
34375-28-5
N-[3-(dodecylamino)propyl]glycine
251-993-4
34395-72-7
2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, monosodium salt
252-204-6
34769-44-3
Sodium 4-ethoxycarbonylphenoxide
252-487-6
35285-68-8
Sodium 4-propoxycarbonylphenoxide
252-488-1
35285-69-9
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide
252-529-3
35367-38-5
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil
252-615-0
35554-44-0
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil
Plant protection product
73790-28-0
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos
252-626-0
35575-96-3
2-bromo-2-(bromomethyl)pentanedinitrile
252-681-0
35691-65-7
Benzyldimethyloleylammonium chloride
253-363-4
37139-99-4
Calcium magnesium oxide/dolomitic lime
253-425-0
37247-91-9
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime
254-454-1
39445-23-3
2-phosphonobutane-1,2,4-tricarboxylic acid
253-733-5
37971-36-1
4-methoxy-m-phenylenediammonium sulphate
254-323-9
39156-41-7
N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]
254-372-6
39236-46-9
Dinocap
254-408-0
39300-45-3
alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
254-484-5
39515-40-7
Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate/Methoprene
254-993-2
40596-69-8
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride
255-451-8
41591-87-1
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol
255-953-7
42822-86-6
4,4-dimethyloxazolidine
257-048-2
51200-87-4
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-cis)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
257-144-4
51348-90-4
Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate/Fenvalerate
257-326-3
51630-58-1
ethyl N-acetyl-N-butyl-.beta.-alaninate
257-835-0
52304-36-6
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin
257-842-9
52315-07-8
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin
258-067-9
52645-53-1
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin
258-256-6
52918-63-5
bis(2-ethylhexanoato-O)-.mu.-oxodizinc
259-049-3
54262-78-1
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin
259-154-4
54406-48-3
3-iodo-2-propynyl butylcarbamate
259-627-5
55406-53-6
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)
259-709-0
55566-30-8
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum
259-978-4
56073-07-5
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum
259-980-5
56073-10-0
[2-(2-butoxyethoxy)ethoxy]methanol
260-097-2
56289-76-0
2-ethoxyethyl bromoacetate
260-240-9
56521-73-4
N-octyl-N′-[2-(octylamino)ethyl]ethylenediamine
260-725-5
57413-95-3
1,2-benzisothiazol-3(2H)-one, sodium salt
261-184-8
58249-25-5
Azaconazole
262-102-3
60207-31-0
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole
262-104-4
60207-90-1
N,N-bis(2-hydroxyethyl)undec-10-enamide
262-114-9
60239-68-1
2-chloro-3-(phenylsulphonyl)acrylonitrile
262-395-8
60736-58-5
Tetradecyldimethylbenzylammonium fluoride
—
61134-95-0
[1,1′-Biphenyl]-2-ol, chlorinated
262-974-5
61788-42-9
Amines, coco alkyl
262-977-1
61788-46-3
Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides
263-005-9
61788-78-1
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides
263-038-9
61789-18-2
Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides
263-078-7
61789-68-2
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides
263-080-8
61789-71-7
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides
263-087-6
61789-77-3
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides
263-090-2
61789-80-8
Quaternary ammonium compounds, trimethylsoya alkyl, chlorides
263-134-0
61790-41-8
Ethanol, 2,2′-iminobis-, N-coco alkyl derivs.
263-163-9
61791-31-9
1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.
263-171-2
61791-39-7
Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides
263-185-9
61791-52-4
Amines, N-tallow alkyldipropylenetri-
263-191-1
61791-57-9
Amines, N-coco alkyltrimethylenedi-
263-195-3
61791-63-7
Amines, N-coco alkyltrimethylenedi-, acetates
263-196-9
61791-64-8
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides
264-151-6
63449-41-2
4,5-dichloro-2-octyl-2H-isothiazol-3-one
264-843-8
64359-81-5
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide
264-980-3
64628-44-0
Distillates (petroleum), solvent-refined light naphthenic
265-098-1
64741-97-5
Distillates (petroleum), hydrotreated light
265-149-8
64742-47-8
N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1,3-dimethyl-2,4-dioxopyrimidine-5-carboxamide
265-732-7
65400-98-8
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
265-898-0
65731-84-2
Tar acids, coal, crude
266-019-3
65996-85-2
Glass powder
266-046-0
65997-17-3
3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin
266-235-8
66204-44-2
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine
266-257-8
66215-27-8
Betaines, C12-C14-alkyl dimethyl
266-368-1
66455-29-6
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylate/Tralomethrin
266-493-1
66841-25-6
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide
266-583-0
67129-08-2
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
266-719-9
67564-91-4
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide
266-994-5
67747-09-5
Fatty acids, C16-18 and C18-unsatd., Me esters
267-015-4
67762-38-3
.alpha-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl cyclopropanecarboxylate/Cyhalothrin
268-450-2
68085-85-8
Dodecylethyldimethylammonium bromide/Laudacit
269-249-2
68207-00-1
Shale oils
269-646-0
68308-34-9
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin
269-855-7
68359-37-5
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
269-919-4
68391-01-5
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides
269-925-7
68391-06-0
Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts
270-115-0
68411-30-3
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides
270-324-7
68424-84-0
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides
270-325-2
68424-85-1
Betaines, coco alkyldimethyl
270-329-4
68424-94-2
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides
270-331-5
68424-95-3
Fatty acids, coco, reaction products with diethanolamine
270-430-3
68440-04-0
1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates
271-063-1
68514-93-2
Amides, coco, N,N-bis(2-hydroxyethyl)
271-657-0
68603-42-9
Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl, dichlorides
271-761-6
68607-28-3
9-Octadecenoic acid (Z)-, sulfonated, potassium salts
271-843-1
68609-93-8
Urea, reaction products with formaldehyde
271-898-1
68611-64-3
Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, sodium salts
272-043-5
68650-39-5
bis(tetraamminecopper) carbonatedihydroxide
272-415-7
68833-88-5
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
272-574-2
68890-66-4
Amines, N-tallowalkyl trimethylenedi-, diacetates
272-786-5
68911-78-4
Quassia, ext.
272-809-9
68915-32-2
Fatty acids, C8-10
273-086-2
68937-75-7
Sulfuric acid, mono-C12-18-alkyl esters, sodium salts
273-257-1
68955-19-1
Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
273-318-2
68956-79-6
Didecylmethyl[3-(trimethoxysilyl)propyl]ammonium chloride
273-403-4
68959-20-6
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides
273-544-1
68989-00-4
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)
273-545-7
68989-01-5
Sodium N-(hydroxymethyl)glycinate
274-357-8
70161-44-3
Amines, C10-16-alkyldimethyl, N-oxides
274-687-2
70592-80-2
Pentapotassium bis(peroxymonosulphate) bis(sulphate)
274-778-7
70693-62-8
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride
274-861-8
70775-75-6
1,3-didecyl-2-methyl-1H-imidazolium chloride
274-948-0
70862-65-6
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb
276-696-7
72490-01-8
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides
277-453-8
73398-64-8
1-[(hydroxymethyl)amino]propan-2-ol
278-534-0
76733-35-2
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea
278-928-2
78491-02-8
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-)
279-013-0
78948-87-5
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate
279-013-0
114915-85-4
Tributyltetradecylphosphonium chloride
279-808-2
81741-28-8
(2-Butoxyethoxy)methanol
281-648-3
84000-92-0
Zinc, isodecanoate isononanoate complexes, basic
282-786-7
84418-73-5
Juniper, Juniperus communis, ext.
283-268-3
84603-69-0
Laurus nobilis, ext.
283-272-5
84603-73-6
Rosemary, ext.
283-291-9
84604-14-8
Eucalyptus globulus, ext.
283-406-2
84625-32-1
Cinnamomum zeylanicum, ext.
283-479-0
84649-98-9
Margosa ext.
283-644-7
84696-25-3
Lavender, Lavandula angustifolia angustifolia, ext.
283-994-0
84776-65-8
Thyme, Thymus serpyllum, ext.
284-023-3
84776-98-7
Formaldehyde, reaction products with diethylene glycol
284-062-6
84777-35-5
Formamide, reaction products with formaldehyde
284-064-7
84777-37-7
Glycine, N-(3-aminopropyl)-, N′-C10-16-alkyl derivs.
284-065-2
84777-38-8
Lemon, ext.
284-515-8
84929-31-7
Thyme, Thymus vulgaris, ext.
284-535-7
84929-51-1
Clove, ext.
284-638-7
84961-50-2
Tar acids, polyalkylphenol fraction
284-893-4
84989-05-9
Melaleuca alternifolia, ext./Australian Tea Tree Oil
285-377-1
85085-48-9
2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt
286-344-4
85209-91-2
Formaldehyde, reaction products with propylene glycol
286-695-3
85338-22-3
Stannane, tributyl-, mono(naphthenoyloxy) derivs.
287-083-9
85409-17-2
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
287-089-1
85409-22-9
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
287-090-7
85409-23-0
[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium methyl sulphate
287-462-9
85508-38-9
Benzenesulfonic acid, 4-C10-13-sec-alkyl derives.
287-494-3
85536-14-7
Guanidine, N,N‴-1,3-propanediylbis-, N-coco alkyl derivs., diacetates
288-198-7
85681-60-3
Sulfonic acids, C13-17-sec-alkane, sodium salts
288-330-3
85711-69-9
.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
289-244-9
86560-93-2
Chrysanthemum cinerariaefolium, ext.
289-699-3
89997-63-7
Cymbopogon nardus, ext.
289-753-6
89998-15-2
Lavender, Lavandula angustifolia, ext.
289-995-2
90063-37-9
Litsea cubeba, ext.
290-018-7
90063-59-5
Mentha arvensis, ext.
290-058-5
90063-97-1
Pelargonium graveolens, ext.
290-140-0
90082-51-2
Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with Me 1H-benzimidazol-2-ylcarbamate
290-651-9
90194-41-5
Copper, EDTA-complexes
290-989-7
90294-99-8
Formaldehyde, reaction products with propanolamine
291-325-9
90387-52-3
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde
292-348-7
90604-54-9
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides
293-522-5
91080-29-4
Fir, Abies sibirica, ext.
294-351-9
91697-89-1
Juniper, Juniperus mexicana, ext.
294-461-7
91722-61-1
Lavender, Lavandula hybrida, ext./Lavandin oil
294-470-6
91722-69-9
Amines, N-(3-aminopropyl)-N′-coco alkyltrimethylenedi-, monoacrylated
294-702-6
91745-32-3
Cymbopogon winterianus, ext.
294-954-7
91771-61-8
Lemongrass (Cymbopogon flexuosus)
295-161-9
91844-92-7
White mineral oil (petroleum), light
295-550-3
92062-35-6
N-[3-(dodecylamino)propyl]glycine hydrochloride
298-216-5
93778-80-4
Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-O2,O3)copper
304-146-9
94246-73-8
Citrus, ext.
304-454-3
94266-47-4
Pine ext.
304-455-9
94266-48-5
Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate
304-990-8
94313-91-4
Peppermint, American, ext.
308-770-2
98306-02-6
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts
309-206-8
100085-64-1
Corn cob, powdered
310-127-6
999999-99-4
Natural lemon juice (filtered)
310-127-6
999999-99-4
Hedera helix
310-127-6
999999-99-4
Onion Oil
310-127-6
999999-99-4
Thuja occidentalis
310-127-6
999999-99-4
Salvia officinalis
310-127-6
999999-99-4
Hyssopus officinalis
310-127-6
999999-99-4
Chrysanthemum vulgare
310-127-6
999999-99-4
Artemisia absinthium
310-127-6
999999-99-4
Achillea millefolium
310-127-6
999999-99-4
Origanum vulgare
310-127-6
999999-99-4
Majorana hortensis
310-127-6
999999-99-4
Origanum majorano
310-127-6
999999-99-4
Rosmarinus officinalis
310-127-6
999999-99-4
Satureja hortensis
310-127-6
999999-99-4
Uritica dioica
310-127-6
999999-99-4
Aesculus hippocastanum
310-127-6
999999-99-4
Symphytum officinale
310-127-6
999999-99-4
Equisetum arvense
310-127-6
999999-99-4
Sambucus nigra
310-127-6
999999-99-4
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron
401-400-1
86479-06-3
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione
401-570-7
89415-87-2
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole
403-640-2
107534-96-3
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine
403-950-8
164907-72-6
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate
404-690-8
68132-19-4
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin
405-060-5
118712-89-3
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon
405-090-9
67485-29-4
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox
407-980-2
80844-07-1
6-(phthalimido)peroxyhexanoic acid
410-850-8
128275-31-0
Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide
411-690-1
111337-53-2
Methyl neodecanamide
414-460-9
105726-67-8
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin
415-130-7
91465-08-6
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron
417-680-3
101463-69-8
2-butyl-benzo[d]isothiazol-3-one
420-590-7
04299-07-4
Tetrachlorodecaoxide complex
420-970-2
92047-76-2
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen
421-960-0
90035-08-8
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine
423-210-8
119515-38-7
N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide
423-990-1
149118-66-1
Fipronil
424-610-5
120068-37-3
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid
428-040-8
138261-41-3
Thiamethoxam
428-650-4
153719-23-4
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin
428-790-6
72963-72-5
5-chloro-2-(4-chlorphenoxy)phenol
429-209-0
3380-30-1
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen
429-800-1
95737-68-1
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide
431-030-6
163269-30-5
Reaction products of diisopropanolamine with formaldehyde(1:4)
432-440-8
220444-73-5
Chloromethyl n-octyl disulfide
432-680-3
180128-56-7
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane
432-790-1
Bis(3-aminopropyl)octylamine
433-340-7
86423-37-2
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine
433-460-1
210880-92-5
(E)-2-Octadecenal
Not yet allocated
51534-37-3
(E,Z)-2,13-Octadecadienal
Not yet allocated
99577-57-8
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing
Not yet allocated
398477-47-9
Silver sodium hydrogen zirconium phosphate
Not yet allocated
Paraformaldehyde
30525-89-4
Peroxyoctanoic acid
33734-57-5
Bromomyristyl isoquinoline
51808-87-8
9-Aminoacridine hydrochloride monohydrate
52417-22-8
Chlorinated trisodium phosphate
56802-99-4
Cyclohexylhydroxydiazene 1-oxide, potassium salt
66603-10-9
(1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol
104870-56-6
Silica, amorphous, crystalline-free
112945-52-5
Denatonium Capsaicinate
192327-95-0
Tris(N-cyclohexyldiazeniumdioxy)aluminium
312600-88-7
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper
312600-89-8
Reaction product of essential oils and ozone in-situ (Open Air Factor (OAF))
Silver zeolite A
Silver sodium borosilicate
5-Chloro-2-(4-chlorophenoxy)phenol
Benzyl-lauryl-dimethyl-myristylammonium chloride/Lauryl-myristyl dimethyl benzyl ammonium chloride
((1,2-Ethanediylbis(carbamodithioato))(2-))manganese mixture with ((1,2-ethandiylbis(carbamodithioate))(2-))zinc/Mancozeb
Plant protection product
8018-01-7
Chlorosulfamic acid
Plant protection product
17172-27-9
2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfos
Plant protection product
33399-00-7
Ethyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate/Hydroprene
Plant protection product
41096-46-2
Silicium dioxide/Kieselguhr
Plant protection product
61790-53-2
.alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-toluidine/Bromethalin
Plant protection product
63333-35-7
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate
Plant protection product
65733-16-6
S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoate
Plant protection product
65733-18-8
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate
Plant protection product
66230-04-4
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cypermethrin
Plant protection product
67375-30-8
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9)
265-610-3
71751-41-2
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate
Plant protection product
82657-04-3
N-(2-((2,6-Dimethyl)phenyl)amino)-2-oxoethyl)-N,N-diethyl benzenemethanaminiumsaccharide/Denatonium Saccharide
Plant protection product
90823-38-4
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/Cyproconazole
Plant protection product
94361-06-5
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone
Plant protection product
104653-34-1
Guazatine triacetate
Plant protection product
115044-19-4
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr
Plant protection product
122453-73-0
Aluminium sodium silicate-silver complex/Silver zeolite
Plant protection product
130328-18-6
Aluminium sodium silicate-silver copper complex/Silver Copper Zeolite
Plant protection product
130328-19-7
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite
Plant protection Product
130328-20-0
N-Isononyl-N,N-dimethyl-N-decylammonium chloride
Plant protection product
138698-36-9
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid
Plant protection product
160430-64-8
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin
Plant protection product
188023-86-1
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)
Plant protection product
[1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dichlorovinyl)-2,2-dimenthylcyclopropanecarboxylate
Plant protection product
S-Cyphenothrin
Plant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-Allethrin
Plant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin
Plant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/Esbiothrin
Plant protection product
Spinosad: fermentation product of soil micro-organism containing Spinosyn A and Spinosyn D
Plant protection product
Butoxy polypropylene glycol
Polymer
9003-13-8
Polydimethylsiloxane
Polymer
9016-00-6
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride
Polymer
25988-97-0
Polymer of N,N,N,N-tetramethyl-ethane-1,2-diamine and (chloromethyl)oxirane
Polymer
25988-98-1
Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4)
Polymer
26716-20-1
Polymer of formaldehyde and acrolein
Polymer
26781-23-7
Monohydro chloride of polymer of N,N‴-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride)
Polymer
27083-27-8/32289-58-0
Polymer of N,N,N′,N′-tetramethyl-1,6-hexanediamine and 1,6-dichlorohexane
Polymer
27789-57-7
Poly(hexamethylendimethylammonium chloride)/Poly[(dimethylimino)-1,6-hexanediyl-chloride]
Polymer
28728-61-2
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer
Polymer
31075-24-8
Poly(hexamethylendiamine guanidinium chloride)
Polymer
57028-96-3
Poly(hexamethylenebiguanide)
Polymer
91403-50-8
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt)
Polymer
94667-33-1
N,N-Didecyl(-N-methyl-poly(oxyethyl)ammoniumpropionate/1-Decanaminium, N-decyl-N-(2-hydroxyethyl)-N-methyl-, propanoate (salt)
Polymer
107879-22-1
Copolymer of 2-propenal and propane-1,2-diol
Polymer
191546-07-3
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate
Polymer
214710-34-6
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)
Polymer
374572-91-5
Tributyltin coPolymer (TBT-coPolymer)
Polymer
Fat alcohol polyglycol ether
Polymer
Poly(vinyl chloride-co-isobutyl vinyl ether-co-N-vinyl, N′-dimethyl octyl bromide propyl diamine)
Polymer
Polyglycolpolyamine resin
Polymer
Sodium lignosulfonate
Natural Polymer
8061-51-6
Neem/Neem-Vital
Natural oil
5945-86-8
Pinus pumilio oil
Natural oil
8000-26-8
Cedarwood oil
Natural oil
8000-27-9
Lavender oil
Natural oil
8000-28-0
Citronella oil
Natural oil
8000-29-1
Essential oil of eugenia caryophyllus
Natural oil
8000-34-8
Geranium oil
Natural oil
8000-46-2
Eucalyptus Oil
Natural oil
8000-48-4
Orange oil
Natural oil
8000-57-9
Pine oil
Natural oil
8002-09-3
Black pepper oil
Natural oil
8006-82-4
Peppermint oil
Natural oil
8006-90-4
Lemongrass oil
Natural oil
8007-02-1
Penny Royal Oil
Natural oil
8007-44-1
Thyme oil
Natural oil
8007-46-3
Coriander oil
Natural oil
8008-52-4
Spearmint oil
Natural oil
8008-75-5
Valeriana officinalis oil
Natural oil
8008-88-6
Cajuput Oil
Natural oil
8008-98-8
Juniperberry oil
Natural oil
8012-91-7
Cypress Oil
Natural oil
8013-86-3
Patchouli oil
Natural oil
8014-09-3
Cumin Oil
Natural oil
8014-13-9
Palmarosa oil
Natural oil
8014-19-5
Rue oil
Natural oil
8014-29-7
Basilicum Ocimum basilium oil
Natural oil
8015-73-4
Bois de rose oil/Rosewood oil
Natural oil
8015-77-8
Celery oil
Natural oil
8015-90-5
Chamomile oil
Natural oil
8015-92-7
Clove leaf oil (Eugenia caryophyllus)
Natural oil
8015-97-2
Melaleuca oil
Natural oil
68647-73-4
Litsea cubeba oil
Natural oil
68855-99-2
Cornmint oil
Natural oil
68917-18-0
Cedar Oil (Cedarwood oil Texas, Juniperus mexicana oil, 22 %)
Natural oil
68990-83-0
Citrus extract of seeds of tabebuia avellanedae
Natural oil
Essential oil of cymbopogon winterianus
Natural oil
Allium sativum and Allium cepa
Natural oil
Essential oil of cinnamomum zeylanicum
Natural oil
Clove oil (main components: Eugenol (83,8 %), Caryophyllene (12,4 %), Eugenol acetate (0,4 %))
Natural oil
Fir needle perfume oil: (Ethereal oil, main components: Turpentine oil (30-37,5 %), Terpineol (15-20 %), Isobornyl acetate (15-20 %), Pinene beta (12,5-15 %), Pinene alpha (7-10 %), Coumarin (1-3 %), Terpineol-fraction (1-3%)
Natural oil
Perfume oil Spring Fresh: ethereal oil: main components: Citral-diethylacetal (Citrathal) (1-3 %), Citronellol (1-3 %), Ylanat (1-3 %), Hivertal (1-3 %), Allylcapronate (1-3 %)
Natural oil
Rosas oil
Natural oil
Natural Pyrethrins
Natural extract
Peat extract
Natural extract
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride
Mixture
8001-54-5
Cetrimide
Mixture
8044-71-1
Mixture of 3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8;) and 3,6-acridinediamine/Acriflavine
Mixture
8048-52-0
Mixture of ((3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8) and 3,6-acridinediamine) hydrochloride)/Acriflavine HCl
Mixture
8063-24-9
Benzalkonium saccharinate/Benzalkonium o-sulfobenzimidate
Mixture
39387-42-3
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Mixture
55965-84-9
Siloxanes and Silicones, di-Me, reaction products with silica/Treated Fumed Silica
Mixture
67762-90-7
Reaction mixture of fatty acids mixed esters (C6-18, derived from coconut oil) with acetic acid and 2,2′-methylenebis(4-chlorophenol)
Mixture
106523-52-8
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid
Mixture
139734-65-9
Quaternary ammonium iodides
Mixture
308074-50-2
Reaction products of 5,5-dimethylhydantoin and formaldehyde
Mixture
Reaction products of 2-(2-butoxyethoxy)ethanol and formaldehyde
Mixture
Reaction products of ethylene glycol and formaldehyde
Mixture
Reaction products of urea, ethylene glycol and formaldehyde
Mixture
Reaction products of chloroacetamide, 2(2-butoxyethoxy)ethanol and formaldehyde
Mixture
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4)
Mixture
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ
Mixture
Potassium salts of fatty acids (C15-21)
Mixture
Acypetacs copper
Mixture
Acypetacs zinc
Mixture
Webbing clothes moths pheromone: components: E,Z-Octadecadi-2,13-enal (75 %) and E-Octadec-2-enal (25 %)
Mixture
Mixture of chromium trioxide (EINECS 215-607-8; 34,2 %), diarsenic pentoxide (EINECS 215-116-9; 24,1 %), copper(II)oxide (EINECS 215-269-1; 13,7 %), water (EINECS 231-791-2; 28 %)
Mixture
Mixture of chlormethylisothiazolinon, ethandiylbisoxybismethanol, methylisothiazolinon
Mixture
Mixture of bromine (EINECS 231-778-1) and hypobromous acid (CAS-No.: 13517-11-8) manufactured in situ
Mixture
Products of natural fermentation of plants in water, sulphur-containing
Mixture
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC
Mixture of EINECS listed substances
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC
Mixture of EINECS listed substances
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC
Mixture of EINECS listed substances
Bacillus thuringiensis
Micro-organism
68038-71-1
Bacillus sphaericus
Micro-organism
143447-72-7
Bacillus thuringiensis +D381is subsp. Israelensis
Micro-organism
Bacillus thuringiensis Var. Kurstaky
Micro-organism
Bacillus thuringiensis subsp. Israelensis Serotype H14
Micro-organism
Bacillus thuringiensis var. israelensis
Micro-organism
Bacillus subtilis
Micro-organism
(1) This substance also has a different CAS number (31654-77-0) according to the ESIS registry.
ANNEX II
ACTIVE SUBSTANCES TO BE EXAMINED UNDER THE REVIEW PROGRAMME
Substance
Rapporteur Member State
EC number
CAS number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Formaldehyde
DE
200-001-8
50-00-0
1
2
3
4
5
6
9
11
12
13
20
22
23
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide
EL
200-076-7
51-03-6
18
19
Bronopol
ES
200-143-0
52-51-7
1
2
3
4
6
7
9
10
11
12
13
22
Diphenoxarsin-10-yl oxide
FR
200-377-3
58-36-6
9
Chlorocresol
FR
200-431-6
59-50-7
1
2
3
4
6
9
10
13
Dichlorvos
IT
200-547-7
62-73-7
18
Ethanol
EL
200-578-6
64-17-5
1
2
3
4
Formic acid
BE
200-579-1
64-18-6
1
2
3
4
5
6
9
11
12
13
Benzoic acid
DE
200-618-2
65-85-0
1
2
3
4
6
11
20
Propan-2-ol
DE
200-661-7
67-63-0
1
2
3
4
5
6
9
10
11
12
Salicylic acid
LT
200-712-3
69-72-7
1
2
3
4
6
Propan-1-ol
DE
200-746-9
71-23-8
1
2
3
4
Hydrogen cyanide
CZ
200-821-6
74-90-8
8
14
18
Ethylene oxide
N
200-849-9
75-21-8
2
20
1,3-dibromo-5,5-dimethylhydantoin
NL
201-030-9
77-48-5
2
11
12
Citric acid
BE
201-069-1
77-92-9
1
2
3
Linalool
DK
201-134-4
78-70-6
19
2-chloroacetamide
EE
201-174-2
79-07-2
3
6
7
9
10
11
13
Bromoacetic acid
ES
201-175-8
79-08-3
4
Glycollic acid
LT
201-180-5
79-14-1
2
3
4
12
Peracetic acid
FI
201-186-8
79-21-0
1
2
3
4
5
6
11
12
L-(+)-lactic acid
DE
201-196-2
79-33-4
2
3
4
6
20
Warfarin
IE
201-377-6
81-81-2
14
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone
UK
201-501-9
83-79-4
17
Symclosene
UK
201-782-8
87-90-1
2
3
4
5
6
7
9
11
12
Chloroxylenol
BE
201-793-8
88-04-0
1
2
3
4
5
6
Biphenyl-2-ol
ES
201-993-5
90-43-7
1
2
3
4
6
7
9
10
13
Naphthalene
UK
202-049-5
91-20-3
19
Dichlorophen
IE
202-567-1
97-23-4
2
3
4
6
7
9
10
11
12
13
Triclocarban
SK
202-924-1
101-20-2
1
2
4
Cinnamaldehyde/3-phenyl-propen-2-al
UK
203-213-9
104-55-2
2
Geraniol
FR
203-377-1
106-24-1
18
19
Glyoxal
FR
203-474-9
107-22-2
2
3
4
6
12
m-Cresol
FR
203-577-9
108-39-4
2
3
Hexa-2,4-dienoic acid/Sorbic acid
DE
203-768-7
110-44-1
1
2
3
4
5
6
7
8
9
10
Glutaral
FI
203-856-5
111-30-8
1
2
3
4
5
6
7
9
10
11
12
13
22
Nonanoic acid
AT
203-931-2
112-05-0
2
10
19
Undecan-2-one/Methyl-nonyl-ketone
ES
203-937-5
112-12-9
19
Propoxur
BE
204-043-8
114-26-1
18
1,3-dichloro-5,5-dimethylhydantoin
NL
204-258-7
118-52-5
2
11
12
Clorophene
N
204-385-8
120-32-1
1
2
3
4
6
Benzyl benzoate
UK
204-402-9
120-51-4
2
18
Benzethonium chloride
BE
204-479-9
121-54-0
1
Fenitrothion
UK
204-524-2
122-14-5
18
Cetalkonium chloride (1)
204-526-3
122-18-9
Benzyldimethyl(octadecyl)ammonium chloride (1)
204-527-9
122-19-0
2-Phenoxyethanol
UK
204-589-7
122-99-6
1
2
3
4
6
7
10
11
13
Cetylpyridinium chloride
UK
204-593-9
123-03-5
1
2
3
4
5
6
7
9
20
Octanoic acid
AT
204-677-5
124-07-2
4
18
Carbon dioxide
FR
204-696-9
124-38-9
14
15
18
19
20
Sodium dimethylarsinate
PT
204-708-2
124-65-2
18
Nitromethylidynetrimethanol
UK
204-769-5
126-11-4
2
3
6
11
12
13
Tosylchloramide sodium
ES
204-854-7
127-65-1
1
2
3
4
5
6
9
10
11
Potassium dimethyldithiocarbamate
UK
204-875-1
128-03-0
2
4
6
9
10
11
12
13
Sodium dimethyldithiocarbamate
UK
204-876-7
128-04-1
2
3
4
5
6
9
10
11
12
13
Warfarin sodium
IE
204-929-4
129-06-6
14
Sodium 2-biphenylate
ES
205-055-6
132-27-4
1
2
3
4
6
7
9
10
13
Captan
IT
205-087-0
133-06-2
6
7
9
10
N-(trichloromethylthio)phthalimide/Folpet
IT
205-088-6
133-07-3
6
7
9
10
Methyl anthranilate
FR
205-132-4
134-20-3
19
N,N-diethyl-m-toluamide
SE
205-149-7
134-62-3
19
22
Thiram
BE
205-286-2
137-26-8
2
6
7
9
10
11
12
Ziram
BE
205-288-3
137-30-4
2
6
7
9
10
11
12
Potassium methyldithiocarbamate
CZ
205-292-5
137-41-7
2
9
11
12
Metam-sodium
BE
205-293-0
137-42-8
2
4
6
9
11
12
13
20
Disodium cyanodithiocarbamate
CZ
205-346-8
138-93-2
2
9
11
12
Benzododecinium chloride (1)
205-351-5
139-07-1
Miristalkonium chloride (1)
205-352-0
139-08-2
1,3-bis(hydroxymethyl)urea
HU
205-444-0
140-95-4
2
6
9
11
12
13
Nabam
PL
205-547-0
142-59-6
2
4
6
9
10
11
12
13
Lauric acid
DE
205-582-1
143-07-7
19
Thiabendazole
ES
205-725-8
148-79-8
2
6
7
8
9
10
11
12
13
20
Benzothiazole-2-thiol
N
205-736-8
149-30-4
2
7
9
11
12
13
Naled
FR
206-098-3
300-76-5
18
Diuron
DK
206-354-4
330-54-1
6
7
10
Diazinon
PT
206-373-8
333-41-5
18
Decanoic acid
AT
206-376-4
334-48-5
4
18
19
Cyanamide
DE
206-992-3
420-04-2
3
18
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one
SK
207-880-7
499-44-5
10
Sodium benzoate
DE
208-534-8
532-32-1
1
2
6
11
20
Dazomet
BE
208-576-7
533-74-4
6
7
8
9
10
11
12
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid
FI
211-986-9
731-27-1
7
8
10
21
Hydroxyl-2-pyridone
FR
212-506-0
822-89-9
2
6
9
10
11
12
13
2,6-dimethyl-1,3-dioxan-4-yl acetate
AT
212-579-9
828-00-2
2
6
11
12
13
Terbutryn
SK
212-950-5
886-50-0
7
9
10
Dichlofluanid
UK
214-118-7
1085-98-9
7
8
10
21
Copper thiocyanate
FR
214-183-1
1111-67-7
21
Tetradonium bromide
N
214-291-9
1119-97-7
1
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin
DE
214-619-0
1166-46-7
18
4,5-dichloro-3H-1,2-dithiol-3-one
PL
214-754-5
1192-52-5
2
6
9
11
12
Diboron trioxide
NL
215-125-8
1303-86-2
8
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime
UK
215-137-3
1305-62-0
2
3
Calcium oxide/lime/burnt lime/quicklime
UK
215-138-9
1305-78-8
2
3
Zinc sulphide
UK
215-251-3
1314-98-3
7
9
10
Copper oxide
FR
215-269-1
1317-38-0
8
Dicopper oxide
FR
215-270-7
1317-39-1
21
Disodium tetraborate, anhydrous
NL
215-540-4
1330-43-4
1
2
7
8
9
10
11
13
2-Butanone, peroxide
HU
215-661-2
1338-23-4
1
2
3
6
9
22
Monolinuron
UK
217-129-5
1746-81-2
2
2,4-dichlorobenzyl alcohol
CZ
217-210-5
1777-82-8
2
6
7
9
10
12
13
Chlorothalonil
NL
217-588-1
1897-45-6
6
7
9
10
Fluometuron
EL
218-500-4
2164-17-2
6
7
9
10
11
12
13
4-(2-nitrobutyl)morpholine
UK
218-748-3
2224-44-4
6
13
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
PT
219-145-8
2372-82-9
1
2
3
4
6
8
9
10
11
12
13
Didecyldimethylammonium bromide (2)
219-234-1
2390-68-3
Tolnaftate
PL
219-266-6
2398-96-1
9
2,2′-dithiobis[N-methylbenzamide]
PL
219-768-5
2527-58-4
6
7
9
12
13
1,2-benzisothiazol-3(2H)-one
ES
220-120-9
2634-33-5
2
6
7
9
10
11
12
13
22
2-methyl-2H-isothiazol-3-one
SI
220-239-6
2682-20-4
2
4
6
7
9
10
11
12
13
22
Sulphuryl difluoride
SE
220-281-5
2699-79-8
8
18
Troclosene sodium
UK
220-767-7
2893-78-9
1
2
3
4
5
6
9
11
12
Sodium dichloroisocyanurate dihydrate
UK
220-767-7
51580-86-0
1
2
3
4
5
6
9
11
12
Mecetronium ethyl sulphate
PL
221-106-5
3006-10-8
1
2
Bis(trichloromethyl) sulphone
LT
221-310-4
3064-70-8
6
9
10
11
12
22
Triclosan
DK
222-182-2
3380-34-5
1
2
3
7
9
Oct-1-ene-3-ol
N
222-226-0
3391-86-4
19
(ethylenedioxy)dimethanol
PL
222-720-6
3586-55-8
2
3
4
6
9
11
12
13
Chlorophacinone
ES
223-003-0
3691-35-8
14
Dipyrithione
SE
223-024-5
3696-28-4
9
Sodium 2,4,6-trichlorophenolate
IE
223-246-2
3784-03-0
2
3
6
9
Pyridine-2-thiol 1-oxide, sodium salt
SE
223-296-5
3811-73-2
2
3
4
6
7
9
10
11
12
13
Methenamine 3-chloroallylochloride
PL
223-805-0
4080-31-3
6
9
12
13
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol
PL
225-208-0
4719-04-4
2
3
4
6
9
11
12
13
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione
ES
226-408-0
5395-50-6
2
3
4
6
9
10
11
12
13
Dimethyldioctylammonium chloride (2)
226-901-0
5538-94-3
N,N′-methylenebismorpholine
AT
227-062-3
5625-90-1
6
9
11
13
Coumatetralyl
DK
227-424-0
5836-29-3
14
Terbuthylazine
UK
227-637-9
5915-41-3
2
11
12
(R)-p-mentha-1,8-diene
PT
227-813-5
5989-27-5
12
Methylene dithiocyanate
FR
228-652-3
6317-18-6
6
7
9
10
11
12
13
22
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione
PL
229-222-8
6440-58-0
2
6
11
12
13
(2-bromo-2-nitrovinyl)benzene
SK
230-515-8
7166-19-0
6
11
12
13
Didecyldimethylammonium chloride
IT
230-525-2
7173-51-5
1
2
3
4
6
7
8
9
10
11
12
13
Benzyldodecyldimethylammonium bromide (1)
230-698-4
7281-04-1
Prometryn
PT
230-711-3
7287-19-6
6
7
9
10
11
12
13
Silver
SE
231-131-3
7440-22-4
2
4
5
9
11
Copper
FR
231-159-6
7440-50-8
2
4
5
11
21
Sulphur dioxide
DE
231-195-2
7446-09-5
1
2
4
5
6
9
11
12
13
20
22
Calcium dihexa-2,4-dienoate
DE
231-321-6
7492-55-9
1
3
6
7
9
20
Iodine
SE
231-442-4
7553-56-2
1
2
3
4
5
6
7
9
10
11
22
Silicon dioxide — amorphous
FR
231-545-4
7631-86-9
3
18
20
Sodium hydrogensulphite
DE
231-548-0
7631-90-5
1
2
4
5
6
9
11
12
13
20
22
Hydrogen chloride/Hydrochloric acid
LV
231-595-7
7647-01-0
2
Sodium chloride
PT
231-598-3
7647-14-5
5
Sodium bromide
NL
231-599-9
7647-15-6
2
4
6
7
9
11
12
13
Orthophosphoric acid
PT
231-633-2
7664-38-2
4
Sodium hypochlorite
IT
231-668-3
7681-52-9
1
2
3
4
5
6
11
12
Disodium disulphite
DE
231-673-0
7681-57-4
1
2
4
5
6
9
11
12
13
20
22
Tetramethrin
DE
231-711-6
7696-12-0
18
Potassium permanganate
SK
231-760-3
7722-64-7
5
Hydrogen peroxide
FI
231-765-0
7722-84-1
1
2
3
4
5
6
11
12
Nitrogen
IE
231-783-9
7727-37-9
18
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole
PL
231-810-4
7747-35-5
6
11
12
13
Sodium sulphite
DE
231-821-4
7757-83-7
1
2
4
5
6
9
11
12
13
20
22
Sodium chlorite
PT
231-836-6
7758-19-2
2
3
4
5
11
12
20
Copper sulphate
FR
231-847-6
7758-98-7
1
2
4
Silver nitrate
SE
231-853-9
7761-88-8
1
Sodium chlorate
PT
231-887-4
7775-09-9
2
5
11
12
Disodium peroxodisulphate/Sodium persulphate
PT
231-892-1
7775-27-1
4
Calcium hypochlorite
IT
231-908-7
7778-54-3
1
2
3
4
5
11
Chlorine
IT
231-959-5
7782-50-5
2
5
11
Ammonium sulphate
UK
231-984-1
7783-20-2
11
12
Silver chloride
SE
232-033-3
7783-90-6
1
2
3
4
5
6
7
9
10
11
13
Creosote
SE
232-287-5
8001-58-9
8
Pyrethrins and Pyrethroids
ES
232-319-8
8003-34-7
18
19
Garlic ext.
PL
232-371-1
8008-99-9
3
4
5
18
19
Lignin
EL
232-682-2
9005-53-2
1
2
3
4
6
7
9
10
11
12
13
Boric acid
NL
233-139-2
10043-35-3
1
2
3
6
7
8
9
10
11
12
13
18
22
Chlorine dioxide
PT
233-162-8
10049-04-4
2
3
4
5
11
12
20
Potassium sulphite
DE
233-321-1
10117-38-1
1
2
4
5
6
9
11
12
13
20
22
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]
LV
233-457-1
10187-52-7
2
3
4
6
7
9
10
11
12
13
2,2-dibromo-2-cyanoacetamide
DK
233-539-7
10222-01-2
1
2
3
4
5
6
7
9
10
11
12
13
Carbendazim
DE
234-232-0
10605-21-7
6
7
9
10
11
12
13
Disodium octaborate tetrahydrate
NL
234-541-0
12280-03-4
1
2
3
6
7
8
9
10
11
12
13
Trimagnesium diphosphide
DE
235-023-7
12057-74-8
18
20
23
Copper(II) carbonate-copper(II) hydroxide (1:1)
FR
235-113-6
12069-69-1
8
Zineb
IE
235-180-1
12122-67-7
21
Ammonium bromide
SE
235-183-8
12124-97-9
2
4
6
7
9
11
12
Hexaboron dizinc undecaoxide/Zinc borate
ES
235-804-2
12767-90-7
9
Pyrithione zinc
SE
236-671-3
13463-41-7
2
6
7
9
10
13
21
Dodecylguanidine monohydrochloride
ES
237-030-0
13590-97-1
1
2
6
7
9
10
11
12
22
Potassium 2-biphenylate
ES
237-243-9
13707-65-8
6
9
10
13
Bromine chloride
NL
237-601-4
13863-41-7
2
11
12
(benzyloxy)methanol
UK
238-588-8
14548-60-8
2
6
9
10
11
13
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper
SE
238-984-0
14915-37-8
9
21
Chlorotoluron
ES
239-592-2
15545-48-9
6
7
9
10
11
12
13
Sodium p-chloro-m-cresolate
FR
239-825-8
15733-22-9
1
2
3
4
6
9
10
13
Chloralose
PT
240-016-7
15879-93-3
14
15
23
Dipotassium disulphite
DE
240-795-3
16731-55-8
1
2
4
5
6
9
11
12
13
20
22
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)
PT
242-354-0
18472-51-0
1
2
3
4
6
Benzoxonium chloride
CY
243-008-1
19379-90-9
1
9
p-[(diiodomethyl)sulphonyl]toluene
UK
243-468-3
20018-09-1
6
7
9
10
12
13
Copper dihydroxide
FR
243-815-9
20427-59-2
8
Disilver oxide
SE
243-957-1
20667-12-3
11
Aluminium phosphide
DE
244-088-0
20859-73-8
14
18
20
23
(benzothiazol-2-ylthio)methyl thiocyanate
N
244-445-0
21564-17-0
2
4
6
7
9
10
11
12
13
Bendiocarb
UK
245-216-8
22781-23-3
18
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin
EL
245-387-9
23031-36-9
18
Potassium (E,E)-hexa-2,4-dienoate
DE
246-376-1
24634-61-5
1
2
3
4
5
6
7
8
9
10
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol
AT
246-764-0
25254-50-6
2
6
9
11
13
2-octyl-2H-isothiazol-3-one
UK
247-761-7
26530-20-1
4
6
7
9
10
11
12
13
Cis-tricos-9-ene
AT
248-505-7
27519-02-4
18
19
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
ES
248-595-8
27668-52-6
2
7
9
10
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine
NL
248-872-3
28159-98-0
7
9
10
21
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone
SE
249-205-9
28772-56-7
14
(Z,E)-tetradeca-9,12-dienyl acetate
AT
250-753-6
30507-70-18
19
Decyldimethyloctylammonium chloride (2)
251-035-5
32426-11-2
Bromochloro-5,5-dimethylimidazolidine-2,4-dione
NL
251-171-5
32718-18-6
2
3
4
5
6
9
11
12
13
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
DE
251-835-4
34123-59-6
6
7
9
10
11
12
13
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide
SE
252-529-3
35367-38-5
18
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil
DE
252-615-0
35554-44-0
2
3
4
13
20
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos
UK
252-626-0
35575-96-3
18
2-bromo-2-(bromomethyl)pentanedinitrile
CZ
252-681-0
35691-65-7
6
7
9
10
11
13
Benzyldimethyloleylammonium chloride (1)
253-363-4
37139-99-4
Calcium magnesium oxide/dolomitic lime
UK
253-425-0
37247-91-9
2
3
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime
UK
254-454-1
39445-23-3
2
3
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
EL
254-484-5
39515-40-7
18
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride
PL
255-451-8
41591-87-1
9
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol
UK
255-953-7
42822-86-6
1
2
19
4,4-dimethyloxazolidine
UK
257-048-2
51200-87-4
6
11
12
13
ethyl N-acetyl-N-butyl-.beta.-alaninate
BE
257-835-0
52304-36-6
19
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin
BE
257-842-9
52315-07-8
8
9
18
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin
IE
258-067-9
52645-53-1
2
3
5
8
9
18
22
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin
SE
258-256-6
52918-63-5
18
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin
BE
259-154-4
54406-48-3
18
3-iodo-2-propynyl butylcarbamate
DK
259-627-5
55406-53-6
6
7
8
9
10
11
13
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)
MT
259-709-0
55566-30-8
2
6
9
11
12
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum
FI
259-978-4
56073-07-5
14
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum
IT
259-980-5
56073-10-0
14
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole
FI
262-104-4
60207-90-1
1
2
4
7
8
9
10
12
13
20
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides (3)
263-038-9
61789-18-2
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides (1)
263-080-8
61789-71-7
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides (2)
263-087-6
61789-77-3
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides (2)
263-090-2
61789-80-8
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides (1)
264-151-6
63449-41-2
4,5-dichloro-2-octyl-2H-isothiazol-3-one
N
264-843-8
64359-81-5
6
7
8
9
10
11
12
21
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide
IT
264-980-3
64628-44-0
18
3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin
AT
266-235-8
66204-44-2
2
6
10
11
12
13
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine
EL
266-257-8
66215-27-8
18
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine/Fenpropimorph
ES
266-719-9
67564-91-4
6
7
8
9
10
12
13
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin
DE
269-855-7
68359-37-5
18
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
IT
269-919-4
68391-01-5
1
2
3
4
5
6
7
9
10
11
12
13
17
22
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides (2)
269-925-7
68391-06-0
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides (1)
270-324-7
68424-84-0
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides
IT
270-325-2
68424-85-1
1
2
3
4
6
7
8
9
10
11
12
13
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides
IT
270-331-5
68424-95-3
1
2
3
4
5
6
7
9
10
11
12
13
22
Fatty acids, coco, reaction products with diethanolamine
HU
270-430-3
68440-04-0
3
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides (1)
273-544-1
68989-00-4
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)
MT
273-545-7
68989-01-5
2
4
11
12
Sodium N-(hydroxymethyl)glycinate
AT
274-357-8
70161-44-3
6
7
Amines, C10-16-alkyldimethyl, N-oxides
PT
274-687-2
70592-80-2
1
2
Pentapotassium bis(peroxymonosulphate) bis(sulphate)
SI
274-778-7
70693-62-8
1
2
3
4
5
11
12
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride
HU
274-861-8
70775-75-6
1
1,3-didecyl-2-methyl-1H-imidazolium chloride
CZ
274-948-0
70862-65-6
2
3
4
6
7
10
11
12
13
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb
DE
276-696-7
72490-01-8
8
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides (2)
277-453-8
73398-64-8
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea
LT
278-928-2
78491-02-8
6
7
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate
PL
114915-85-4
2
3
4
Tributyltetradecylphosphonium chloride
PL
279-808-2
81741-28-8
2
4
9
11
12
Margosa ext.
DE
283-644-7
84696-25-3
18
19
Tar acids, polyalkylphenol fraction
HU
284-893-4
84989-05-9
2
3
Melaleuca alternifolia, ext./Australian Tea Tree Oil
ES
285-377-1
85085-48-9
1
2
3
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
IT
287-089-1
85409-22-9
1
2
3
4
5
6
7
9
10
11
12
13
17
22
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
IT
287-090-7
85409-23-0
1
2
3
4
5
6
9
11
12
13
17
22
Chrysanthemum cinerariaefolium, ext.
ES
289-699-3
89997-63-7
18
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde
PL
292-348-7
90604-54-9
2
6
11
12
13
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides (1)
293-522-5
91080-29-4
Lavender, Lavandula hybrida, ext./Lavandin oil
PT
294-470-6
91722-69-9
19
Pine ext.
LV
304-455-9
94266-48-5
10
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts
LT
309-206-8
100085-64-1
1
2
3
4
6
7
10
11
12
13
Corn cob, powdered
EL
310-127-6
999999-99-4
14
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron
PT
401-400-1
86479-06-3
18
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione
NL
401-570-7
89415-87-2
2
11
12
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole
DK
403-640-2
107534-96-3
7
8
9
10
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine
DE
403-950-8
164907-72-6
1
2
3
4
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate
PL
404-690-8
68132-19-4
6
7
9
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin
NL
405-060-5
118712-89-3
18
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon
IE
405-090-9
67485-29-4
18
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox
AT
407-980-2
80844-07-1
2
3
8
18
6-(phthalimido)peroxyhexanoic acid
IT
410-850-8
128275-31-0
1
2
3
4
11
12
Methyl neodecanamide
ES
414-460-9
105726-67-8
19
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin
SE
415-130-7
91465-08-6
18
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron
FR
417-680-3
101463-69-8
8
18
2-butyl-benzo[d]isothiazol-3-one
CZ
420-590-7
4299-07-4
6
7
9
10
13
Tetrachlorodecaoxide complex
DE
420-970-2
92047-76-2
1
2
3
4
5
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen
NL
421-960-0
90035-08-8
14
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine
DK
423-210-8
119515-38-7
19
Fipronil
FR
424-610-5
120068-37-3
18
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
PL
426-020-3
51229-78-8
6
9
12
13
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid
DE
428-040-8
138261-41-3
18
Thiamethoxam
ES
428-650-4
153719-23-4
8
9
18
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin
UK
428-790-6
72963-72-5
18
5-chloro-2-(4-chlorphenoxy)phenol
AT
429-290-0
3380-30-1
1
2
4
6
9
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen
NL
429-800-1
95737-68-1
18
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide
PT
431-030-6
163269-30-5
4
6
7
9
10
13
Reaction products of diisopropanolamine with formaldehyde(1:4)
HU
432-440-8
220444-73-5
6
13
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane
HU
432-790-1
-
1
2
3
4
5
11
12
Bis(3-aminopropyl)octylamine
CZ
433-340-7
86423-37-2
2
3
4
11
12
13
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine/Chlothianidin
DE
433-460-1
210880-92-5
3
8
18
Peroxyoctanoic acid
FR
33734-57-5
2
3
4
11
12
Cyclohexylhydroxydiazene 1-oxide, potassium salt
AT
66603-10-9
6
7
8
9
10
11
12
13
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper
AT
312600-89-8
2
6
7
8
9
10
11
12
Silver zeolite A
SE
-
2
4
5
7
9
Bacillus sphaericus
IT
Micro-organism
143447-72-7
2
18
Bacillus thuringiensis subsp. Israelensis Serotype H14
IT
Micro-organism
-
2
5
18
Bacillus subtilis
DE
Micro-organism
-
3
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride (1)
Mixture
8001-54-5
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
FR
Mixture
55965-84-9
2
3
4
6
7
9
10
11
12
13
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid
IE
Mixture
139734-65-9
1
2
3
4
6
7
10
11
12
13
Quaternary ammonium iodides
ES
Mixture
308074-50-2
1
2
3
4
5
6
7
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4)
UK
Mixture
-
1
2
3
4
6
10
11
13
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ
SK
Mixture
-
2
3
4
5
Potassium salts of fatty acids (C15-21)
DE
Mixture
-
2
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC
IT
Mixture of EINECS listed substances
-
1
2
3
4
6
7
8
9
10
11
12
13
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC
IT
Mixture of EINECS listed substances
-
1
2
3
4
6
7
8
9
10
11
12
13
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC
IT
Mixture of EINECS listed substances
-
8
Sodium lignosulfonate
HU
Natural Polymer
8061-51-6
12
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing
SE
Not yet allocated
398477-47-9
1
2
6
7
9
Silver sodium hydrogen zirconium phosphate
SE
Not yet allocated
-
1
2
3
4
7
9
10
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil
DE
Plant protection product
73790-28-0
2
3
4
13
Silicium dioxide/Kieselguhr
FR
Plant protection product
61790-53-2
18
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate
IE
Plant protection product
65733-16-6
18
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate
PT
Plant protection product
66230-04-4
18
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cypermethrin
BE
Plant protection product
67375-30-8
6
9
18
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9)
NL
265-610-3
71751-41-2
18
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate
FR
Plant protection product
82657-04-3
8
18
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/Cyproconazole
IE
Plant protection product
94361-06-5
8
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone
N
Plant protection product
104653-34-1
14
Guazatine triacetate
UK
Plant protection product
115044-19-4
2
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr
PT
Plant protection product
122453-73-0
6
7
8
9
10
12
13
18
Aluminium sodium silicate-silver complex/Silver zeolite
SE
Plant protection product
130328-18-6
6
7
13
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite
SE
Plant protection Product
130328-20-0
1
2
6
7
9
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid
BE
Plant protection product
160430-64-8
18
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin
IE
Plant protection product
188023-86-1
18
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)
PL
Plant protection product
-
6
13
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-Allethrin
DE
Plant protection product
-
18
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin
DE
Plant protection product
-
18
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/Esbiothrin
DE
Plant protection product
-
18
Spinosad: fermentation product of soil micro-organisms containing Spinosyn A and Spinosyn D
NL
Plant protection product
-
3
18
Polyvinylpyrrolidone iodine
SE
Polymer
25655-41-8
1
2
3
4
5
6
7
9
10
11
22
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride
HU
Polymer
25988-97-0
2
11
12
Polymer of formaldehyde and acrolein
HU
Polymer
26781-23-7
3
Monohydro chloride of polymer of N,N′′′-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride)
FR
Polymer
27083-27-8/32289-58-0
1
2
3
4
5
6
9
11
12
22
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer
UK
Polymer
31075-24-8
2
9
11
12
13
Poly(hexamethylendiamine guanidinium chloride)
FR
Polymer
57028-96-3
1
2
3
4
5
6
7
9
10
11
12
13
20
Poly(hexamethylenebiguanide)
FR
Polymer
91403-50-8
1
2
3
4
9
10
11
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt)
IT
Polymer
94667-33-1
2
3
4
6
8
9
10
11
12
13
Copolymer of 2-propenal and propane-1,2-diol
HU
Polymer
191546-07-3
6
7
10
13
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate
EL
Polymer
214710-34-6
2
6
8
9
10
11
12
13
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)
FR
Polymer
374572-91-5
1
2
3
4
5
6
7
9
10
11
12
13
20
(1) Covered by Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC.
(2) Covered by Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC.
(3) Covered by Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC.
ANNEX III
Requirements for the complete dossier and the summary dossier
(a)
The complete dossier must include the original test and study reports for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB thereto, together with the summary dossier referred to in Article 11(1)(b) of that Directive.
(b)
The summary dossier must include the following:
—
in the case of a collective dossier, the name of all participants concerned and a person designated by them as being responsible for the collective dossier and the processing of the dossier in accordance with this Regulation,
—
for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB to the Directive, the summaries and results of studies and trials,
—
list of references used,
—
risk assessment,
—
overall summary and assessment,
—
a check by the participant or, where appropriate, by the person designated as responsible for a collective dossier of the completeness of the dossier.
(c)
The formats made available by the Commission must be used for submission of the dossiers. In addition, the special software package (IUCLID) made available by the Commission must be used for those parts of the dossiers to which IUCLID applies. Formats and further guidance on data requirements and dossier preparation are available on the ECB homepage http://ecb.jrc.it/biocides
(d)
For existing active substances that have been or are being evaluated under the review programme for plant protection products in accordance with Article 8(2) of Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), the required format for an application for inclusion in Annex I thereto may be used for the preparation of the dossier for inclusion of the existing active substance in Annex I, IA or IB to Directive 98/8/EC, taking into account relevant differences in the dossier requirements. A summary of the dossier must be entered in IUCLID. Additional information related to the biocidal use must be submitted in accordance with the requirements of this Regulation.
(1) OJ L 230, 19.8.1991, p. 1.